Methods and compositions for identifying tumor models

Through deep secondary sequencing technology, the SNP genotype in the sample was detected, combined with map analysis and statistical models, the problems of misidentification and contamination detection in cell line and tumor model identification were solved, and the identification of high sensitivity and high accuracy was achieved, reducing the Maintenance cost of biological sample library.

CN113614246BActive Publication Date: 2024-11-12CROWN BIOSCIENCE (SUZHOU) INC
View PDF 19 Cites 0 Cited by

Patent Information

Application Number
CN202080005269.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-03-12
Filing Date
2020-03-12
Publication Date
2024-11-12
Estimated Expiration
2040-03-12

AI Technical Summary

Technical Problem

The existing cell line and tumor model identification methods have problems with misidentification, misuse, cross-contamination and genome changes, resulting in insufficient detection sensitivity and accuracy, especially in the complex genome changes caused by long-term culture and gene drift, which is difficult to be effective. Identify and identify the true composition of cell lines and tumor models.

Method used

The genotypes of multiple human or mouse single nucleotide polymorphism (SNP) loci in the sample were detected by deep secondary sequencing (NGS) technology, and the genotype of the sample was compared with the reference genotype to determine the sample's Identification information, combined with SNP map analysis and statistical models, achieve high sensitivity and high accuracy identification of cell lines and tumor models.

Benefits of technology

Achieve high sensitivity (≤1%) and high accuracy pollution detection for cell lines and tumor models, can accurately identify interspecies contamination between humans and mice, and reduce the maintenance cost of biological sample libraries, providing a high Low throughput and cost-effective tool for maintaining high-quality biosample library.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The present disclosure provides methods and compositions, such as kits, for identifying or authenticating a sample (eg, a tumor model) based on its genotype at a set of SNP loci.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to application PCT / CN2019 / 077750 filed on March 12, 2019, the disclosure of which is incorporated herein by reference. Technical Field

[0003] The present invention generally relates to molecular biology, cancer biology and animal models. Background Art

[0004] Cell lines, organoids, xenografts, and syngeneic models are useful model systems in oncology and other biomedical research. Model identification and characterization facilitate their proper use and mitigate a range of issues, such as misidentification and misuse, cross-contamination, incorrect cancer classification, genomic changes due to long-term culture, and genetic drift, which have received particular attention for cell lines due to their ubiquitous use. For example, various studies have reported misidentification / contamination rates of approximately 10-40% for cell line libraries.

[0005] There are many methods for identifying cell lines, including cell morphology, isozymology, cytogenetic analysis (karyotyping and FISH), human lymphocyte antigen (HLA) typing, short tandem repeat (STR) profiling, single nucleotide polymorphism (SNP) typing, DNA and RNA sequencing (Freedman, LP et al., Biotechniques 59, 189-90, 192 (2015); Nims, RW and Reid, Y. In Vitro Cell Dev Biol Anim 53, 880-887 (2017)). Among these techniques, STR profiling has been the most widely used and has a standard (ASN-0002) to guide its application in identifying human cell lines (Almeida, JL, Cole, KD & Plant, AL, PLoS Biol 14, e1002476 (2016)). A set of 19 STR markers has also been developed for mouse cell lines (Zaaijer, S. et al., Elife 6 (2017)). The sensitivity of STR analysis for detecting contaminants is about 5-10% (Yu, M. et al., Nature 520, 307-11 (2015)). In recent years, SNP typing has been increasingly used for cell line and biological sample identification due to improved accuracy, sensitivity and reduced costs. SNP profiling can be performed by PCR and next generation sequencing (NGS), including transcriptomic sequencing or RNA-seq, whole exome sequencing (WES) and whole genome sequencing (WGS). The detection sensitivity of current SNP analysis is about 3-5%. There are also databases of STR, SNP and other information of cell lines that help them identify and characterize.

[0006] In addition to cell lines, organoids and mouse tumor models are widely used in oncology research and drug development. Organoids are three-dimensional cultures in vitro derived from stem cells, primary and engineered tumor samples, and xenografted human tumors that maintain a variety of biological structures and functions. Mouse tumor models are in vivo systems, including patient-derived xenografts (PDX), cell line-derived xenografts (CDX), models derived from syngeneic genes or mouse cell lines, mouse homologous transplant models, etc. Some of these models, such as PDX, can capture the histopathology and genomics of primary tumors more faithfully than cell lines. Similar to cell lines, these tumor models not only have similar quality control problems, but also have other problems. In xenograft models, tumors contain human tumor cells and mouse stromal cells, which gradually replace human counterparts during the passage of the model, which, when combined with genomic heterogeneity, implantation site differences (subcutaneous and in situ), growth changes, and anatomical randomness, make the human-mouse genetic composition of tumors from the same PDX very different, so that some samples are almost pure human or mouse components. Such tumor-host mixing and interference are present in all implanted tumor models, resulting in fluctuations in the allele frequencies of STR markers and SNPs, thus adversely affecting traditional STR- and SNP-based identification methods. Large-scale sample identification is also logistically burdensome and error-prone, especially when maintaining and using biobanks of many types of in vitro and in vivo models. Therefore, there is a need to develop new SNP-based assays to identify and authenticate tumor models. Summary of the invention

[0007] In one aspect, the present disclosure provides a method for identifying or authenticating a sample. In one embodiment, the method comprises: obtaining nucleic acid from a sample; detecting the genotype of the sample at multiple human single nucleotide polymorphism (SNP) loci or at multiple mouse SNP loci; comparing the genotype of the sample with a reference genotype; and determining the identification information of the sample. In certain embodiments, the human SNP is selected from the group shown in Table 1. In certain embodiments, the mouse SNP is selected from the group shown in Table 2.

[0008] In certain embodiments, the sample is a cell, tissue, organoid or a combination thereof. In certain embodiments, the sample is a cell line or tumor tissue. In certain embodiments, the sample is derived from a xenograft or a homograft tumor model. In certain embodiments, the sample is derived from a patient-derived xenograft (PDX), a cell line-derived xenograft (CDX), a model derived from a syngeneic gene or a mouse cell line, a mouse homograft model.

[0009] In certain embodiments, the sample comprises a contaminant, and the method further comprises determining the percentage of the contaminant in the sample. In certain embodiments, the method further comprises determining the nature of the contaminant.

[0010] In certain embodiments, the detecting step uses next generation sequencing (NGS) or a sequencing-based SNP array. In certain embodiments, the nucleic acid is barcoded.

[0011] In certain embodiments, the method further comprises the gender of the subject from which the sample is derived. In certain embodiments, the method further comprises the race of the subject from which the sample is derived. In certain embodiments, the method further comprises the presence of a virus or mycoplasma in the detection sample. In certain embodiments, the method further comprises the strain of the immunodeficient mouse from which the sample is derived.

[0012] In another aspect, the present disclosure provides a method for identifying a sample comprising a human component and a mouse component. In certain embodiments, the method includes obtaining nucleic acid from a sample; detecting the genotype of the sample at 100 or more mouse genomic loci, each of which has a corresponding homologous human genomic locus, wherein each mouse genomic locus and the corresponding homologous human genomic locus have a consistent flanking nucleotide sequence; and determining the ratio of the mouse component in the sample based on the genotype. In certain embodiments, the mouse genomic locus is selected from Table 6.

[0013] In another aspect, the present disclosure provides a kit for identifying a sample. In certain embodiments, the kit comprises primers for detecting a sample at a set of human SNP loci or at a set of mouse SNP loci. In certain embodiments, the kit further comprises a reagent for amplifying a DNA fragment containing a human or mouse SNP using primers.

[0014] In another aspect, the present disclosure provides a microarray for identifying a human or mouse sample. In certain embodiments, the microarray comprises probes for detecting the genotype of a sample at a set of human or mouse SNP loci.

[0015] In yet another aspect, the present disclosure provides a non-transitory computer-readable medium storing instructions, wherein when the instructions are executed by a processor, the processor is caused to: retrieve the genotype of the sample at a set of human or mouse SNP loci; compare the genotype of the sample with a reference genotype; and determine identification information of the sample.

[0016] In yet another aspect, the present disclosure provides a method for identifying a sample comprising a major component and a minor component. In certain embodiments, the method includes detecting the genotype of the sample at 100 or more SNP loci; determining the SNP heterogeneity ratio of each SNP locus according to the formula shown in Table 11; using a Gaussian mixture distribution that simulates the genotype, the sample heterogeneity ratio is determined based on the SNP heterogeneity ratio of the SNP locus; and determining the major component of the sample as follows: comparing the genotype of the sample with a set of reference genotypes each detected in a reference sample, identifying a reference sample with the highest consistency between the reference genotype and the sample genotype, and determining that the major component is a reference sample if the following conditions are met: (i) the reference genotype is greater than 90% consistent with the sample genotype and the sample heterogeneity ratio is less than 10%, or (ii) the reference genotype is greater than 80% consistent with the sample genotype and the sample heterogeneity ratio is greater than 10%.

[0017] In certain embodiments, the method further comprises determining a minor component of the sample. In certain embodiments, the method further comprises determining the percentage of a major component and a minor component in the sample. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The following drawings form part of this specification and are included to further demonstrate certain aspects of the present disclosure. The present disclosure may be better understood by referring to one or more of these drawings in conjunction with the detailed description of specific embodiments presented herein.

[0019] Figures 1A-1C Cell line identification and sample genetic heterogeneity are shown. Figure 1A : Genotypic similarity of unrelated / mismatched, identical, and closely related cell line pairs. Figure 1B : Heterogeneity ratios of 118 uncontaminated cell lines, 220 PDXs, and 31 PDXO models. Figure 1C : Heteroplasmy ratios are positively correlated with mouse ratios in PDX models.

[0020] Figures 2A-2D show that the heterogeneity ratio can be used to detect and quantify contamination. Figures 2A-2D: A series of mixtures of cell lines MV-4-11 (MV411) and LNCaP clone FGC (LNCAPCLONEFGC), the latter with cell ratios of 5%, 2.5%, 1.25% and 0.625%, Figure 2E: Pure LNCaP clone FGC cell line, Figure 2F: Pure MV-4-11 cell line. Each tick above the horizontal axis represents an informative SNP site with a corresponding SNP heterogeneity ratio. The probability density is estimated by assuming a 2 / 3 component Gaussian mixture distribution. The sample number is marked in the box on the upper right, with the main component cell lines in brackets. The sample heterogeneity ratio is shown below.

[0021] Figures 3A-3F Contamination detection, contaminant inference, and contamination ratio estimation are shown. Figure 3A: Sample 19R58129 is a mixture of MV411 and a minor contaminating cell line, LNCaP clone FGC (LNCAPCLONEFGC). LNCAPCLONEFGC was correctly identified as a contaminant (p-value = 5.01E-17) with a contamination ratio of 1.41%. Both LNCaP-C4-2 (C42) and LNCAPCLONEFGC are derived from LNCaP and share a high genetic consistency. In the quantile-quantile plot, each point is a reference cell line, and the theoretical and sample quantiles are calculated using a beta distribution fitted with the genotype similarity between the MV411 and 1055 reference cell lines. The 99% confidence band is shaded. Figure 3B: The accuracy of inferring a contaminating second cell line in a cell line based on different heterogeneity ratios. A total of 94 cell line samples with known contaminating second cell lines were tested, and the samples were grouped according to the heterogeneity ratio. Figure 3C: The cell line "G-292 Clone A141B1" has a sample heterogeneity ratio of 7.62%, and the probability density of the SNP heterogeneity ratio shows an obvious right peak, indicating that it is contaminated. Figure 3D: OCI-AML-2 is inferred to be a contaminant in the cell line "G-292 Clone A141B1" (p value = 1.58E-07) with a contamination ratio of 6.21%. Figure 3E: There is almost a perfect correlation between the estimated contamination ratio and the known contamination ratio in the simulated cell line mixture. Figure 3F: The heterogeneity ratio of the cell line samples with known contamination is highly correlated with the contamination ratio.

[0022] Figures 4A-4D Estimation of mouse ratio in human-mouse mixtures is shown. Figure 4A: Mouse ratios were accurately estimated by deep NGS sequencing of a series of human-mouse DNA mixtures with mouse ratios of 90%, 80%, 70%, 50%, 30%, 20%, 10%, 7%, 5%, and 0%. Figures 4B-4C: Mouse ratios in 220 PDX and 31 PDX-derived organoid models estimated by three methods, with the same samples analyzed for each model. Figure 4D: Quadratic relationship between mouse ratios estimated by deep NGS sequencing and WES in 220 PDX models. DETAILED DESCRIPTION

[0023] Before describing the present disclosure in more detail, it should be understood that the present disclosure is not limited to the specific embodiments described, and as such may of course vary. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only, and is not intended to be limiting, as the scope of the present disclosure is limited only by the appended claims.

[0024] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which the present disclosure belongs. Although any methods and materials similar or equivalent to those described herein can be used to implement or test the present disclosure, preferred methods and materials are now described.

[0025] All publications and patents cited in this specification are incorporated herein by reference, just as if each individual publication or patent was specifically and individually indicated to be incorporated by reference, and are incorporated herein by reference for the purpose of disclosing and describing the methods and / or materials related to the referenced publication. Reference to any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present disclosure is not entitled to antedate such disclosure based on prior disclosure. In addition, the dates of disclosures provided may differ from the actual publication dates which may need to be independently confirmed.

[0026] As will be apparent to those skilled in the art after reading this disclosure, each individual embodiment described and illustrated herein has discrete components and features that can be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure. Any of the methods described can be performed in the order of events described or in any other order that is logically possible.

[0027] definition

[0028] The following definitions are provided to assist the reader. Unless otherwise defined, all technical terms, symbols and other scientific or medical terms used herein are intended to have the meanings commonly understood by those skilled in the art of chemistry and medicine. In some cases, for the sake of clarity and / or for ready reference, terms with commonly understood meanings are defined herein, and the inclusion of such definitions herein should not necessarily be interpreted as representing substantial differences from the definitions of terms commonly understood in the art.

[0029] As used herein, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0030] The term "allele" refers to one of two or more existing genetic variants of a particular polymorphic locus.

[0031] The term "amount" or "level" refers to the number of polynucleotides of interest or polypeptides of interest present in a sample. Such quantities can be expressed in absolute terms, i.e., the total number of polynucleotides or polypeptides in the sample, or in relative terms, i.e., the concentration of the polynucleotides or polypeptides in the sample.

[0032] As used herein, the term "cancer" or "tumor" refers to any disease involving abnormal cell growth and includes all stages and all forms of diseases that affect any tissue, organ or cell in the body. The term includes all known cancers and neoplastic conditions (whether characterized by malignant, benign, soft tissue, or solid), as well as all stages and severity grades of cancer, including pre-metastatic and post-metastatic cancers. In general, cancer can be classified according to the tissue or organ in which the cancer is located or derived and the morphology of the cancer tissue and cells. As used herein, cancer types include, but are not limited to, acute lymphoblastic leukemia (ALL), acute myeloid leukemia, adrenocortical carcinoma, anal cancer, astrocytoma, childhood basal cell carcinoma of the cerebellum or cerebrum, bile duct cancer, bladder cancer, bone tumors, brain cancer, cerebellar astrocytoma, cerebral astrocytoma / malignant glioma, ependymoma, medulloblastoma, supratentorial primitive neuroectodermal tumor, optic pathway and hypothalamic glioma, breast cancer, Burkitt's lymphoma, cervical cancer, chronic lymphocytic leukemia, chronic myeloid leukemia, colon cancer, emphysema, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, retinoblastoma, gastric (stomach) cancer, glioma, head and neck cancer, heart cancer, Hodgkin lymphoma, lymphoma), islet cell carcinoma (endocrine pancreas), Kaposi sarcoma, kidney cancer (renal cell carcinoma), laryngeal cancer, leukemia, liver cancer, lung cancer, neuroblastoma, non-Hodgkin lymphoma, ovarian cancer, pancreatic cancer, pharyngeal cancer, prostate cancer, rectal cancer, renal cell carcinoma (kidney cancer), retinoblastoma, Ewing family tumor, skin cancer, stomach cancer, testicular cancer, laryngeal cancer, thyroid cancer, vaginal cancer.

[0033] As used herein, "cell" can be prokaryotic or eukaryotic. Prokaryotic cells include, for example, bacteria. Eukaryotic cells include, for example, fungi, plant cells, and animal cells. Types of animal cells (e.g., mammalian cells or human cells) include, for example, cells from the circulating / immune system or organs (e.g., B cells, T cells (cytotoxic T cells, natural killer T cells, regulatory T cells, T helper cells), natural killer cells, granulocytes (e.g., basophils, eosinophils, neutrophils and hypersegmented neutrophils), monocytes or macrophages, red blood cells (e.g., reticulocytes), mast cells, platelets or megakaryocytes, and dendritic cells); cells from the endocrine system or organs (e.g., thyroid cells (e.g., thyroid epithelial cells, parafollicular cells), parathyroid cells (e.g., parathyroid chief cells, eosinophils), adrenal cells (e.g., chromaffin cells), and pineal cells (e.g., pinealocytes)); cells from the nervous system or organs (e.g., glial cells (e.g., astrocytes and oligodendritic glial cells), microglial cells, magnocellular neurosecretory cells, astrocytes, Boettcher cells); cells) and pituitary cells (e.g., gonadotropins, corticotropins, thyrotropins, somatotropins, and prolactin cells); cells from the respiratory system or organs (e.g., lung cells (type I pneumocytes and type II pneumocytes), Klebsiella cells, goblet cells, alveolar macrophages); cells from the circulatory system or organs (e.g., cardiomyocytes and pericytes); cells from the digestive system or organs (e.g., gastric chief cells, parietal cells, goblet cells, Paneth cells, G cells, D cells, ECL cells, I cells, K cells, S cells, endocrine cells, enterochromaffin cells, APUD cells, liver cells (e.g., hepatocytes and Kupffer cells); ll)); cells from the epidermal system or organs (e.g., bone cells (e.g., osteoblasts, osteocytes, and osteoclasts), tooth cells (e.g., cementoblasts and ameloblasts), cartilage cells (e.g., chondroblasts and chondrocytes), skin / hair cells (e.g., nematodes, keratinocytes, and melanocytes (nevus cells)), muscle cells (e.g., myocytes), adipocytes, fibroblasts, and tendon cells), cells from the urinary system or organs (e.g., podocytes, juxtaglomerular cells, glomerular mesangial cells, extraglomerular mesangial cells, renal proximal tubule brush border cells, and macula densa cells), and cells from the reproductive system or organs (e.g., sperm, Sertoli cells, leydig cells, egg cells, oocytes). The cell may be a normal, healthy cell; or a diseased or unhealthy cell (e.g., a cancer cell). The cell further includes a mammalian zygote or stem cell, including embryonic stem cells, fetal stem cells, induced pluripotent stem cells, and adult stem cells.Stem cell is a cell that can undergo a cell division cycle, maintain an undifferentiated state and differentiate into a specialized cell type. Stem cell can be a totipotent stem cell, a pluripotent stem cell, a multipotent stem cell, an oligopotent stem cell and a unipotent stem cell, any of which can be induced by somatic cells. Stem cell can also include cancer stem cells. Mammalian cells can be rodent cells, such as mice, rats, hamster cells. Mammalian cells can be rabbit cells, such as rabbit cells. Mammalian cells can also be primate cells, such as human cells. In some instances, cells are cells for large-scale biological production, such as CHO cells.

[0034] The term "complementarity" refers to the ability of a nucleic acid to form hydrogen bonds with another nucleic acid sequence through traditional Watson-Crick or other non-traditional types. The complementarity percentage represents the percentage of residues in a nucleic acid molecule that can form hydrogen bonds (e.g., Watson-Crick base pairing) with a second nucleic acid sequence (e.g., 5 / 10, 6 / 10, 7 / 10, 8 / 10, 9 / 10, 10 / 10 are 50%, 60%>, 70%>, 80%>, 90% and 100% complementary). "Complete complementarity" refers to that all continuous residues of a nucleic acid sequence will be hydrogen bonded with the same number of continuous residues in a second nucleic acid sequence. As used herein, "substantially complementary" refers to a degree of complementarity of at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, 98%, 99%, or 100% over a region of 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50 or more nucleotides, or to two nucleic acids hybridizing under stringent conditions.

[0035] Note that in this disclosure, terms such as "comprises / comprised / comprising", "contains / containing", etc. have the meanings ascribed to them in U.S. patent law; they are inclusive or open-ended, and do not exclude other unrecited elements or method steps. Terms such as "consisting essentially of / consists essentially of" have the meanings ascribed to them in U.S. patent law; they permit the inclusion of other ingredients or steps that do not materially affect the basic and novel characteristics of the claimed invention. The terms "consists of / consisting of" have the meanings ascribed to them in U.S. patent law; i.e., these terms are closed-ended.

[0036] As used herein, the term "contaminant" refers to a component present in a sample that is different from the main component in the sample or causes impurities or other undesirable effects on the sample, such as damage, corruption, infection, etc.

[0037] The terms "determining," "assessing," "analyzing," "measuring," and "detecting" are used interchangeably and designate both quantitative and semi-quantitative determinations. Where quantitative and semi-quantitative determinations are intended, the phrases "determining the level of a polynucleotide or polypeptide of interest" or "detecting" a polynucleotide or polypeptide of interest may be used.

[0038] The term "genome" refers to the total genetic information carried by an individual organism or cell, represented by the complete DNA sequence of its chromosomes.

[0039] The term "hybridization" refers to the preferential binding, duplex formation or hybridization of a nucleic acid molecule to a specific nucleotide sequence under stringent conditions. The term "stringent conditions" refers to the conditions under which a probe preferentially hybridizes to its target subsequence, under which the probe binds less to other sequences in a mixed population, or does not bind to other sequences in a mixed population at all (e.g., cell lysates or DNA preparations from tissue sections). In the context of nucleic acid hybridization (e.g., arrays, microarrays, DNA hybridizations, or RNA hybridizations), "stringent hybridization" and "stringent hybridization wash conditions" are sequence-dependent and are different under different environmental parameters. For in-depth guidance on nucleic acid hybridization, see, for example, Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Acid Probes, Overview of principles of hybridization and the strategy of nucleic acid assays, Part I, Chapter 2, (1993), Elsevier, NY. In general, highly stringent hybridization and washing conditions are selected to be about 5°C lower than the thermal melting point (Tm) of a specific sequence at a defined ionic strength and pH. Tm is the temperature (under defined ionic strength and pH) at which 50% of a target sequence hybridizes to a fully matched probe. Extremely stringent conditions are selected to be equal to the Tm of a specific probe. In Southern or Northern blot hybridization, an example of stringent hybridization conditions for hybridization of complementary nucleic acids with more than 100 complementary residues on an array or on a filter is 42°C, using a standard hybridization solution (see, e.g., Sambrook and Russell, Molecular Cloning: A Laboratory Manual (3rd Edition) Vol. 1-3 (2001), Cold Spring Harbor Laboratory, Cold Spring Harbor Press, NY). An example of highly stringent washing conditions is 0.15M NaCl, 72°C, about 15 minutes. An example of stringent washing conditions is 0.2×SSC wash solution, 65°C, 15 minutes. Typically, a low stringency wash is performed before a high stringency wash to remove background probe signal. An example of a medium stringency wash for a duplex of, for example, more than 100 nucleotides is 1×SSC, 45° C., 15 minutes.An example of a low stringency wash for a duplex of, e.g., more than 100 nucleotides is 4X SSC to 6X SSC, 40°C, 15 minutes.

[0040] The term "locus" refers to any segment of a DNA sequence in a genome, defined according to chromosomal coordinates in a reference genome known in the art, regardless of biological function. A DNA locus can contain multiple genes or no genes; it can be a single base pair or millions of base pairs.

[0041] The terms "nucleic acid" and "polynucleotide" are used interchangeably and refer to a polymeric form of nucleotides of any length: deoxyribonucleotides or ribonucleotides, or their analogs. Polynucleotides can have any three-dimensional structure and can perform any known or unknown function. Non-limiting examples of polynucleotides include genes, gene fragments, exons, introns, messenger RNA (mRNA), transfer RNA, ribosomal RNA, ribozymes, cDNA, shRNA, single-stranded short or long RNA, recombinant polynucleotides, branched polynucleotides, plasmids, vectors, isolated DNA of any sequence, control regions, isolated RNA of any sequence, nucleic acid probes and primers. Nucleic acid molecules can be linear or circular.

[0042] The term "oligonucleotide" refers to a nucleic acid sequence of at least about five nucleotides to about 500 nucleotides (e.g., 5, 6, 7, 8, 9, 10, 12, 15, 18, 20, 21, 22, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 100, 125, 150, 175, 200, 250, 300, 350, 400, 450, or 500 nucleotides). In some embodiments, for example, an oligonucleotide can be about 15 nucleotides to about 30 nucleotides, or about 20 nucleotides to about 25 nucleotides, which can be used, for example, as a primer in a polymerase chain reaction (PCR) amplification assay and / or as a probe in a hybridization assay or in a microarray. As is well known in the art, the oligonucleotides of the present invention can be natural or synthetic, such as DNA, RNA, PNA, LNA, modified backbones, etc.

[0043] The term "polymorphic locus" refers to a genomic locus at which two or more alleles have been identified.

[0044] As used herein, the term "reference genotype" refers to a predetermined genotype of one or more genomic loci present in a reference sample (e.g., a sample of known properties). The reference genotype is suitable for use in the inventive method as a basis for comparing the genotype of a specific genomic locus present in a test sample. The reference genotype can vary depending on the properties of the sample and other factors, such as the sex, age, race of the subject, and such reference samples are established based on the subject.

[0045] The term "sample" or "biological sample" is used herein to refer to any cell, tissue, organoid, or any other sample containing one or more nucleic acid molecules of interest. In certain embodiments, the sample is a cell (e.g., a normal cell, a cancer cell, a cell line), a tissue (e.g., a normal tissue, a cancer tissue, a xenograft or an allograft tissue), an organoid, etc.

[0046] The term "single nucleotide polymorphism" or "SNP" refers to a single nucleotide position in a genomic sequence where two or more alternative alleles are present in a population at significant frequencies (e.g., >1%). SNPs can be present in the coding sequence of a gene, in the non-coding regions of a gene, and / or in the intergenic (e.g., intron) regions of a gene. SNPs that are not present in protein coding regions can still affect gene splicing, transcription factor binding, and / or the sequence of non-coding RNA. The SNP nomenclature provided herein refers to the official reference SNP (rs) identification number assigned to each unique SNP by the National Center for Biotechnological Information (NCBI), which can be found in obtained from the database.

[0047] As used herein, the term "subject" refers to a human or any non-human animal (e.g., mouse, rat, rabbit, dog, cat, cow, pig, sheep, horse, or primate). Humans include prenatal and postnatal forms. In many embodiments, the subject is a human. The subject can be a patient, which refers to a person presented to a medical provider for the purpose of diagnosing or treating a disease. The term "subject" is used interchangeably herein with "individual" or "patient". A subject may suffer from or be susceptible to a disease or condition, but may or may not show symptoms of the disease or condition.

[0048] The term "substrate" refers to a material capable of loading related analysis components (e.g., analysis area, cells, test compounds, etc.) when used in the context of an array. The example of a substrate includes, but is not limited to, glass, Si-based materials, functionalized polystyrene, functionalized polyethylene glycol, functionalized organic polymers, nitrocellulose or nylon membranes, paper, cotton, and materials suitable for synthesis. The substrate is not necessarily flat and includes any type of shape, including spherical (e.g., beads). The material attached to the substrate can be attached to any part of the substrate (e.g., it can be attached to the inside of a porous substrate material). The preferred embodiment of the technology of the present invention has a nucleic acid probe attached to a substrate. When the nucleic acid probe is associated with a substrate by non-random chemical or physical interactions, the nucleic acid probe is "attached" to the substrate. In some preferred embodiments, attachment is achieved by a covalent bond (e.g., a covalent bond provided by a connexon).

[0049] As used herein, the term "tumor model" refers to cells, tissues, or animals used to study the development and progression of cancer and to test treatments before administering them to humans.

[0050] The term "tumor sample" includes a biological sample or a sample from a biological source containing one or more tumor cells. Biological samples include samples from body fluids (e.g., blood, plasma, serum, or urine), or samples derived from (e.g., by biopsy) cells, tissues, or organs, preferably from tumor tissue suspected of including or consisting essentially of cancer cells.

[0051] SNPs used to identify tumor samples

[0052] Misidentification and contamination of biobank samples (e.g., cell lines) have plagued biomedical research. Short tandem repeat (STR) and single nucleotide polymorphism (SNP) analysis has been widely used to identify biological samples and can detect contamination with a sensitivity of 5-10% and 3-5%, respectively. The present disclosure provides, in one aspect, a contamination detection method with a sensitivity of ≤1%. It can further identify contaminants and estimate the contamination ratio of mixed cell line samples. It is the most sensitive and accurate cell line identification method reported to date. In certain embodiments, the method can also detect interspecies contamination of human-mouse mixed samples (e.g., xenograft tumors) and accurately estimate the mouse ratio. In certain embodiments, mycoplasma and Mollicutes are also one of the targets searched. In certain embodiments, this versatile method simultaneously infers the population structure and gender of human samples. In certain embodiments, due to DNA barcoding technology, the method disclosed herein can perform profile analysis on 100-200 samples in a single operation at a cost per sample similar to conventional STR analysis, making it a truly high-throughput, low-cost tool for maintaining high-quality biobanks.

[0053] The methods and compositions described herein are based in part on the discovery of a group of SNP loci that can be used to identify and characterize samples obtained from tumor models. In a particular embodiment, the tumor model is a human tumor model, including primary human tumors, patient-derived xenografts (PDX), human tumor cell lines, human cell line-derived xenografts, and human organoids. In certain embodiments, SNPs are selected from human SNPs, which are based on RNAseq or whole exome sequencing (WES) data from a variety of human tumor models. The selected human SNPs are located in the exon regions of highly expressed genes, which are mainly located in non-linkage disequilibrium (non-LD) blocks of 22 autosomes. Therefore, each human tumor model has a unique genotype (i.e., SNP fingerprint) at the selected human SNP loci.

[0054] In certain embodiments, selected human SNP locus has homology in mouse genome.When using the primer amplification sample targeting this type of human SNP locus, if the sample is mixed with mouse cells or tissue, the nucleotide sequence of the corresponding mouse locus can be produced.This type of human SNP can be used to estimate the mouse component percentage in the mixture of human and mouse cells / tissues, for example, based on the number of mouse and human reads in these SNPs to estimate.

[0055] In certain embodiments, the human SNPs used herein are selected from the group shown in Table 1.

[0056] In certain embodiments, the SNPs include a set of mouse SNPs to identify and characterize mouse tumor models, such as mouse tumor cell lines. In some embodiments, the mouse SNPs used herein are selected from the group shown in Table 2.

[0057] In certain embodiments, the SNPs further include human SNPs in sex chromosomes (chromosome X and chromosome Y) that determine the sex of the subject from which the sample is obtained. In certain embodiments, the sex chromosome SNPs are selected from the group shown in Table 3.

[0058] In certain embodiments, the SNPs further include mouse SNPs that can be used to determine the strain of immunodeficient mouse from which the sample was obtained. In some embodiments, the SNPs are shown in Table 4.

[0059] method

[0060] In one aspect, the present disclosure provides a method for identifying or authenticating a sample.

[0061] In certain embodiments, the method disclosed herein is to match a sample with a reference (e.g., a standard cancer cell line). Conventional STR and SNP analysis mostly uses the Tanabe-Master algorithm based on genotype and its variations. STR analysis produces analog signals of multiple markers. SNP analysis usually performs genotyping on more SNPs. Therefore, SNP analysis usually uses a higher similarity threshold to judge that two samples match. However, even with about 100 SNPs, the matching ability of conventional analysis is seriously impaired due to sample contamination. In certain embodiments, the method disclosed herein performs high depth (3000X) sequencing of 237 SNP sites of human samples and shows 100% accuracy in identifying the main components of samples or contaminated samples.

[0062] In certain embodiments, the method disclosed herein is to detect contamination in biological samples. The sensitivity of STR analysis for detecting cell line contamination is about 5-10%, while the sensitivity of SNP analysis for detecting cell line contamination is 3-5%. However, the detection performance may be quite unstable, so that 96-SNP analysis can not even detect >20% contamination in a mixture of two unrelated cell lines (Liang-Chu, MM et al., "Public Library of Science Comprehensive (PLoS One)" 10, e0116218 (2015)). In certain embodiments, when only the heterogeneity ratio is used, the method disclosed herein always reaches 2% sensitivity according to its value and unique bimodal / trimodal distribution. If the contaminant is present in a reference sample library with SNP fingerprints, the sensitivity reaches ≤1%. Since uncontaminated cell lines exhibit a level of genetic heterogeneity comparable to that of cell line samples with about 1% contamination due to polyclonal and sequencing errors, such sensitivity is almost the theoretical detection limit.

[0063] In certain embodiments, the method disclosed herein is to identify pollutants. Cross contamination of cell lines is common in biological sample banks. The composition of contaminated cultures changes over time due to the different growth rates of cell lines. Cell lines are different in genomics (e.g., gene mutations) and may have different responses to drug treatments, resulting in erroneous results during drug screening. The inventors of the present disclosure have constructed a SNP fingerprint library of more than 1000 cancer cell lines, which can clearly identify contaminated cell lines using this SNP fingerprint library. In addition, the contamination ratio can be accurately estimated. In addition to checking the quality of cell lines, this ability can have other uses, such as monitoring the dynamic composition of two cell lines under biological or chemical interference.

[0064] In certain embodiments, method disclosed herein can also detect accurately and quantitatively the interspecific pollution between human and mouse.In certain embodiments, method disclosed herein does not use SNP, but uses 108 homologous DNA segments, and described homologous DNA segments are divergent between two species, but have consistent side joint nucleotide sequence, therefore can design the universal primer for carrying out unbiased amplification to human and mouse DNA segments.This method has shown perfect performance to a series of mouse-human DNA mixture reference samples.The principle based on homology can be used to detect other interspecific pollution.

[0065] In certain embodiments, the capabilities of the methods disclosed herein come from several novel features. First, deep NGS sequencing obtains the genotype and nucleotide frequency of SNPs, while conventional STR and SNP analysis only performs map analysis on SNP genotypes. Secondly, in addition to SNP map analysis, the methods disclosed herein also perform targeted sequencing to detect mycoplasma contamination and estimate mouse-human mixing ratios. Third, a set of statistical models and algorithms that utilize deep NGS sequencing data have been developed to make the identification method automated, stable, and objective. Finally, the use of DNA barcoding technology enables parallel sequencing of 100-200 samples at the same time, significantly reducing costs.

[0066] The high-throughput, low-cost method disclosed herein can be used routinely by biological sample banks to maintain reliable and high-quality samples. The method can be widely applicable to samples from other substances and even microbial groups, and can be implemented on any NGS sequencing platform.

[0067] In one embodiment, the method comprises: obtaining nucleic acid from a sample; detecting the genotype of the sample at a plurality of human or mouse single SNP loci disclosed herein; comparing the sample genotype with a reference genotype detected in a reference sample; and determining the identity of the sample. In certain embodiments, the genotypes of 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200 or more SNP loci are detected.

[0068] The nucleic acid obtained from the sample can be RNA or DNA. In certain embodiments, the nucleic acid obtained from the sample is genomic DNA isolated from the sample. In certain embodiments, the nucleic acid obtained from the sample is genomic DNA, total RNA or mRNA isolated from the sample. In certain embodiments, the nucleic acid obtained from the sample is amplified, for example, by PCR reaction or PCR after reverse transcription.

[0069] The genotype of a sample at a SNP locus can be detected based on any suitable method known in the art, such as, but not limited to, a sequencing-based method and a hybridization-based method.

[0070] In certain embodiments, the detection step involves an amplification step. In this case, the detection agent comprises at least one pair of primers that can hybridize with a genomic region containing a SNP locus and amplify a polynucleotide sequence containing a SNP locus in the presence of a polymerase. The primer pair for amplifying a genomic region containing a SNP has sufficient consistency or complementarity with at least a portion of the genomic region, so that the primer or probe can specifically hybridize with the genomic region or its complementary strand. As used herein, "specifically hybridize" means that the primer or probe can hybridize with a specified sequence under stringent conditions. As used herein, "stringent conditions" refers to hybridization at 42°C in a solution consisting of 5×SSPE, 5×Denhardt's solution, 0.5%SDS, and 100ug / mL denatured salmon sperm DNA, followed by washing at 42°C with a solution containing 0.5×SSC and 0.1%SDS.

[0071] In certain embodiments, the sequence or SNP in the amplified product is detected after amplification by a suitable nucleic acid amplification method (e.g., PCR). In certain embodiments, the amplified product has a length of 50bp-500bp. In certain embodiments, the SNP sequence in the amplified product is detected using a method based on sequencing (e.g., next generation sequencing (NGS) method). In certain embodiments, the sequence of many SNP loci is determined using the NGS method. In certain embodiments, the NGS method can be used to simultaneously determine the SNP loci sequence of multiple samples by realizing barcoding of the nucleic acid obtained from each sample.

[0072] When the nucleic acid obtained from the sample is RNA, the amplification step may optionally include a reverse transcription step to produce cDNA of the sample RNA. The cDNA is then amplified using primers to detect the presence of SNPs.

[0073] In certain embodiments, the SNP in nucleic acid is detected using, for example, a microarray. The microarray is composed of a reproducible pattern of capture probes attached to a solid support. Labeled RNA or DNA is hybridized with complementary probes on the array and then detected by laser scanning. The presence of SNP can be detected by measuring the intensity of the labeled RNA or DNA that is bound to the specific probe on the array.

[0074] The technology of synthesizing these arrays using mechanical synthesis methods is described in, for example, U.S. Patent No. 5,384,261. Although a flat array surface is generally used, the array can be made on a surface of almost any shape or even multiple surfaces. The array can also be a nucleic acid on a bead, gel, polymer surface, fiber (e.g., optical fiber), glass, or any other suitable substrate, see U.S. Patent Nos. 5,770,358, 5,789,162, 5,708,153, 6,040,193, and 5,800,992. The array can be packaged in a manner that allows diagnosis or other manipulation of an inclusive device.

[0075] The probe and primer required for implementing the present invention can be synthesized and labeled using well-known technology. The oligonucleotide used as probe and primer can be according to Beaucage and Caruthers, " Tetrahedron Letters (Tetrahedron Letts.) " (1981) 22:1859-1862 first described solid phase phosphoramidite triester method, use such as Needham-Van Devanter et al., " Nucleic Acids Research (Nucleic Acids Res.) " (1984) 12:6159-6168 described in the automated synthesizer chemical synthesis.

[0076] In certain embodiments, the method further comprises identifying the sex of the subject from which the sample is obtained, for example, by detecting a sex chromosome SNP selected from a group as shown in Table 3. In certain embodiments, the method further comprises identifying the race of the subject from which the sample is obtained. In certain embodiments, the method further comprises determining the strain of the immunodeficient mouse from which the sample is obtained, for example, by detecting a supplier SNP as shown in Table 4.

[0077] In certain embodiments, the methods disclosed herein further include detecting common viral infections and mycoplasma contamination in tumor models, including hepatitis A / B / C viruses (HAV / HBV / HCV), human immunodeficiency virus (HIV), Epstein-Barr virus (EBV) and human papillomavirus (HPV). In certain embodiments, markers for detecting viral infection and mycoplasma contamination are shown in Table 5.

[0078] In certain embodiments, the methods disclosed herein can be used to identify samples comprising major components and minor components. In certain embodiments, the methods include estimating heterogeneity ratios; determining the major components of the sample; determining the minor components of the sample; and estimating the mixing ratio of the major and minor components.

[0079] In certain embodiments, the heterogeneity ratio can be estimated as follows. There are six informative genotype combinations, using which the heterogeneity ratio can be estimated from deep NGS sequencing data (Table 11). It exhibits four different nucleotide frequency patterns. Combinations 1 and 2 produce the same pattern, and we use the average formula to calculate the percentage or heterogeneity ratio of the minor component S2. When two combinations occur with equal frequency, the formula produces an accurate estimate of the ratio, which is a situation that should be approximately estimated when the number of SNPs is large. Combinations 4 and 5 use a similar averaging method. When the heterogeneity ratio is low, sequencing errors may interfere with the inference of the heterogeneity ratio. In order to alleviate this problem, a 2-step statistical procedure can be used. Assuming that at a specified SNP site, the sequencing error is e=0.001 and the sequencing depth is n (n≥500, discarding any SNP of n<500), the probability of observing k erroneous nucleotides follows the binomial distribution of parameters n and e.

[0080]

[0081] For each n, the cumulative density function can be calculated to obtain a threshold value h, so that the probability of observing more than h erroneous nucleotides in n nucleotides is less than 0.01. In the sequencing data, any low-frequency nucleotides with a read number less than the corresponding threshold h are discarded. The parameters of the Gaussian mixture distribution (with 1 to 3 components) are then estimated using the expectation maximization algorithm (package mclust in R, version 3.5.3), which simulates the distribution of nucleotide frequencies less than the maximum heterogeneity (0.2 is used for all samples in this study). If there is only a single Gaussian component, or the Gaussian component with the smallest mean value accounts for more than 60% of all data points, then the median of all data points is taken as the sample heterogeneity ratio, otherwise the median of the data points in other Gaussian components is taken as the sample heterogeneity ratio.

[0082] In order to determine the main component in the sample, only nucleotides with allele frequencies greater than a threshold (10% for the reference sample and 25% for the test sample that may be contaminated) are used to determine the genotype of the SNP site. The genotype similarity between the reference sample and the test sample is the percentage of SNPs with the same genotype in the test sample, excluding SNPs with a sequencing depth of less than 500. The main component of the test sample is the reference sample with the highest genotype similarity. If the heterogeneity ratio of the test sample is <10% (or>10%), then the highest genotype similarity must be greater than 90% (or 80%). Otherwise, it cannot be called the main component.

[0083] After estimating the heterogeneity ratio and determining the main component, the minor component of the test sample can be determined. For a mixture of the main component and one of the other reference samples (e.g., all cell lines with genomic data), a mosaic genotype with possible 1 to 4 nucleotides can be obtained for each SNP site. Nucleotide frequencies are calculated using the heterogeneity ratio. Similarly, the mosaic genotype of the test sample is obtained. Two mosaic genotypes are considered to be the same if they have the same nucleotides and the frequency of each nucleotide is within three times the range. The genotype similarity between the test sample and each reference sample merged with the main component is then calculated. All paired genotype similarity sets are then fitted according to a beta distribution with parameters (α, β)

[0084]

[0085] In the equation, Γ(α) is the γ function and x is the genotype similarity. Its parameters are estimated by the package fitdistrplus (version 3.5.3) in R. Based on the fitted beta distribution, the probability of observing any genotype similarity greater than a specific value is calculated. A quantile-quantile plot with a 99% confidence band is drawn for all observed genotype similarities for visualization. If (1) the reference sample has the highest genotype similarity, (2) its genotype similarity is higher than the 99% confidence limit in the quantile-quantile plot, and (3) its p-value is <1.0E-6 in the fitted beta distribution, then the reference sample is considered a minor component.

[0086] The mixing ratio of two reference samples can be estimated as follows. Assume that the mixing ratio of two components S1 and S2 is θ for S1 and (1-θ) for S2, where 0≤θ≤1. According to the deep NGS sequencing data, the nucleotide frequencies of all n SNPs in the two components can be accurately estimated. For one SNP, the frequencies of its four nucleotides are expressed, totaling 1, which is expressed as {A1, T1, G1, C1} for component S1 and {A2, T2, G2, C2} for component S2. In principle, if the SNP is homozygous, one of the frequencies is approximately 1, and if the SNP is heterozygous, both frequencies are approximately 0.5. The actual data has some deviations due to sequencing errors and randomness and polyclonal cell lines.

[0087] According to the sequencing data of the mixed sample, the actual occurrence of the four nucleotides is represented by x = {n A , n T , n G , n C}. The likelihood of such an observation is

[0088]

[0089] The likelihood P of any SNPi∈(1, 2, ..., n) θ (x i ) can use the observed data x i Calculate the observed data X of all SNPs = {x1, x2, ..., x n The likelihood of} is

[0090]

[0091] The log-likelihood is therefore

[0092]

[0093] The θ that maximizes the likelihood can be solved by incrementally increasing θ.

[0094] Kits and Microarrays

[0095] In another aspect, the disclosure provides a kit for use in the above-mentioned method. The kit may include any or all reagents for performing the methods described herein. In certain embodiments, the kit includes primers for detecting a set of human SNP loci or a set of mouse SNP loci in a sample. In certain embodiments, the kit further includes primers for detecting sex chromosome SNPs to identify the gender of the subject from which the sample is obtained. In certain embodiments, the kit further includes primers for detecting ethnic SNPs to identify the race of the subject from which the sample is obtained. In certain embodiments, the kit further includes primers for detecting supplier SNPs to determine the strain of immunodeficient mice from which the sample is obtained. In certain embodiments, the kit further includes primers for detecting viral infection or mycoplasma contamination in the sample.

[0096] In certain embodiments, the kit further comprises a reagent for amplifying a DNA fragment containing a human or mouse SNP using a primer. In addition, the kit may include explanatory materials containing instructions (i.e., protocols) for implementing the methods provided herein. Although the explanatory materials typically include written or printed materials, they are not limited thereto. The present invention encompasses any medium capable of storing such instructions and communicating them with an end user. Such media include, but are not limited to, electronic storage media (e.g., disks, tapes, cassettes, chips), optical media (e.g., CD ROMs), etc. Such media may include the website address of an Internet website providing such explanatory materials.

[0097] In another aspect, the present disclosure provides oligonucleotide probes attached to a solid support, such as an array slide or chip, such as described in DNA Microarrays: A Molecular Cloning Manual (2003), edited by Bowtell and Sambrook (Cold Spring Harbor Laboratory Press). The construction of such devices is well known in the art, such as described in the following U.S. patents and patent publications: U.S. Patent No. 5,837,832; PCT Application No. WO95 / 11995; U.S. Patent No. 5,807,522; U.S. Patent Nos. 7,157,229, 7,083,975, 6,444,175, 6,375,903, 6,315,95 No. 8, No. 6,295,153 and No. 5,143,854, No. 2007 / 0037274, No. 2007 / 0140906, No. 2004 / 0126757, No. 2004 / 0110212, No. 2004 / 0110211, No. 2003 / 0143550, No. 2003 / 0003032 and No. 2002 / 0041420. Nucleic acid arrays are also reviewed in the following references: Biotechnol Annu Rev (2002) 8:85-101; Sosnowski et al., Psychiatr Genet (2002) 12(4):181-92; Heller, Annu Rev Biomed Eng (2002) 4:129-53; Kolchinsky et al., Hum. Mutat (2002) 19(4):343-60; and McGail et al., Adv Biochem Eng Biotechnol (2002) 77:21-42.

[0098] Microarray can be made of many unique single-stranded polynucleotides (generally synthetic antisense polynucleotides or fragments) of the cDNA fixed on the solid support. Typical polynucleotide preferably has a length of about 6-60 nucleotide, more preferably a length of about 15-30 nucleotide, and most preferably a length of about 18-25 nucleotide. For some types of array or other detection kit / system, it is possible to preferably use oligonucleotides of only about 7-20 nucleotide in length. In other types of arrays (arrays used in conjunction with chemiluminescent detection techniques), preferred probe length can be, for example, a length of about 15-80 nucleotide, preferably a length of about 50-70 nucleotide, more preferably a length of about 55-65 nucleotide and most preferably a length of about 60 nucleotide.

[0099] Computer-implemented methods, systems and devices

[0100] Any method described herein can be performed in whole or in part with a computer system comprising one or more processors, and the computer system can be configured to perform the steps. Therefore, the embodiment is about a computer system configured to perform any method steps described herein, which potentially has different components for performing corresponding steps or corresponding step groups. Although the method steps herein are presented as numbered steps, they can be performed simultaneously or in different orders. In addition, a part of these steps can be used in conjunction with a part of other steps of other methods. In addition, all or a part of the steps can be optional. Any step of any method can be performed with a module, a circuit or other devices for performing these steps.

[0101] Any computer system mentioned herein can use any suitable number of subsystems. In some embodiments, the computer system includes a single computer device, wherein the subsystem can be a component of the computer device. In other embodiments, the computer system can include multiple computer devices, each of which is a subsystem with internal components. The subsystems can be interconnected through a system bus. Other subsystems include, for example, printers, keyboards, storage devices, monitors coupled to a graphics card, and other components. Peripheral devices and input / output (I / O) devices coupled to an I / O controller can be connected to the computer system by any number of methods known in the art (e.g., serial ports). For example, a serial port or an external interface (e.g., Ethernet, Wi-Fi, etc.) can be used to connect the computer system to a wide area network, such as the Internet, a mouse input device, or a scanner. Interconnection through the system bus allows the central processor to communicate with each subsystem and control the execution of instructions and information exchange between the subsystems by a system memory or storage device (e.g., a fixed disk, such as a hard disk drive or an optical disk). The system memory and / or storage device can be embodied as a computer-readable medium. Any data mentioned herein can be output from one component to another and can be output to a user.

[0102] A computer system may include multiple identical components or subsystems, such as multiple identical components or subsystems connected together through an external interface or through an internal interface. In some embodiments, the computer system, subsystem, or device can communicate via a network. In such cases, one computer may be considered a client and another computer may be considered a server, each of which may be part of the same computer system. The client and server may each contain multiple systems, subsystems, or components.

[0103] It should be understood that any embodiment of the present disclosure can be implemented in a modular or integrated manner in a form of logic control, using hardware (e.g., an application specific integrated circuit or a field programmable gate array) and / or using computer software, using a general programmable processor. As used herein, a processor includes a multi-core processor located on the same integrated chip, or multiple processing units located on a single circuit board or networked. Based on the disclosure and teachings provided herein, those skilled in the art will know and understand other ways and / or methods of implementing the embodiments of the present disclosure using hardware and a combination of hardware and software.

[0104] Any of the software components or functions described in this application may be implemented in the form of software code, which is executed by a processor using any suitable computer language (e.g., Java, C++, or Perl), using, for example, conventional or object-oriented techniques. The software code may be stored as a series of instructions or commands on a computer-readable medium for storage and / or transmission, and suitable media include random access memory (RAM), read-only memory (ROM), magnetic media (e.g., hard disk drive or floppy disk) or optical media (e.g., compact disk (CD) or DVD (digital versatile disk)), flash memory, etc. The computer-readable medium may be any combination of such storage or transmission devices.

[0105] Such programs can also be encrypted and transmitted using carrier signals, which are suitable for transmission via wired, optical and / or wireless networks (including the Internet) that meet multiple agreements. Therefore, the computer-readable medium according to an embodiment of the present invention can be generated using data signals encrypted to such programs. The computer-readable medium encrypted to program code can be packaged with compatible devices or provided separately from other devices (e.g., downloaded via the Internet). Any such computer-readable medium can be present on or inside a single computer product (e.g., hard drive, CD, or entire computer system), and can be present on or inside different computer products in a system or network. The computer system can include a monitor, a printer, or other suitable displays so that any result mentioned herein is provided to the user.

[0106] The following examples are provided to better illustrate the claimed invention and should not be construed as limiting the scope of the present invention. All of the following specific compositions, materials and methods fall within the scope of the present invention in whole or in part. These specific compositions, materials and methods are not intended to limit the present invention, but only illustrate specific embodiments falling within the scope of the present invention. Those skilled in the art can develop equivalent compositions, materials and methods without the need for the exercise of inventive ability and without departing from the scope of the present invention. It should be understood that many changes can be made to the procedures described herein, but they are still within the scope of the present invention. The inventors hope that such variations are included within the scope of the present invention.

[0107] Example 1

[0108] Materials and methods

[0109] Nucleic acid extraction

[0110] Genomic DNA was purified from cells, PDX and PDXO using DNeasy blood and tissue kit (QIAGEN, catalog number 69506, California) according to the manufacturer's instructions. DNA integrity was determined by 2100 bioanalyzer (Agilent) and quantified using NanoDrop (Thermo Scientific). Deep NGS sequencing and WES sequencing were performed using an aliquot of high-quality DNA samples (OD260 / 280=1.8-2.0, OD260 / 230≥2.0,>1 μg). Total RNA was purified from cells, PDX and PDXO using RNeasy mini kit (QIAGEN, catalog number 74106, California) according to the manufacturer's instructions. The integrity of total RNA was determined by 2100 bioanalyzer (Agilent) and quantified using NanoDrop (Thermo Scientific). One aliquot of high-quality RNA samples (OD260 / 280=1.8-2.2, OD260 / 230≥2.0, RIN≥8.0, >1 μg) was used for deep NGS sequencing and RNAseq sequencing.

[0111] Cell line mixture preparation

[0112] Cell line mixtures were prepared by mixing cells of two cell lines at a specified ratio. Based on cell growth rate, cells were inoculated in 15 ml of culture medium in T75 to 60%-80% cell fullness, followed by overnight cultivation in a CO2 water jacketed incubator (SANYO). Cells were collected during the logarithmic growth phase and counted with a hemocytometer (Chongguang) to calculate concentration. Cells of the two cell lines were then mixed to establish a cell line mixture according to a predefined ratio, followed by centrifugation at 3,000 rpm for 5 minutes. Supernatant was aspirated and cell pellets were stored at -20°C for DNA extraction.

[0113] Human-mouse DNA mixture preparation

[0114] A series of mouse-human DNA mixture benchmark samples were prepared by mixing mouse spleen DNA and human genomic DNA (Thermo Scientific, catalog number 4312660). Using DNeasy blood and tissue kit (Qiagen, catalog number 69506, California), mouse spleen DNA was purified according to the manufacturer's instructions and quantified using NanoDrop (Thermo Scientific). Mouse spleen DNA and human genomic DNA were diluted to 200ng / μL and then mixed according to a predefined ratio. DNA mixtures were subsequently used for deep NGS sequencing.

[0115] Barcode Deep NGS Sequencing

[0116] Multiplex PCR was used to prepare target sequencing libraries for Illumina sequencers, with paired-end read lengths of 150 bp (pE150). NGS deep sequencing covers 630 amplicons with a size range of 160 bp to 260 bp. Genomic DNA was amplified using IGT-EM808 polymerase mixture (iGene Tech Bioscience Co., Ltd., 95°C for 3 minutes and 30 seconds, 18 cycles of cultivation: 98°C for 20 seconds and 60°C for 8 minutes, 72°C for 5 minutes), then purified by AMPure XP beads (Beckman Coulter, catalog number A63881).

[0117] Barcoding was performed by a second round of amplification. Briefly, the purified target amplicon was used as a template and an upstream IGT-I5 index primer (10 μM), a downstream IGT-I7 index primer (10 μM) and a polymerase mixture were added for PCR reaction. The mixture was then placed in a thermal cycler with the following settings for amplification: 95°C for 3 minutes and 30 seconds, 9 cycles of cultivation: 98°C for 20 seconds, 58°C for 1 minute and 72°C for 30 seconds, and kept at 72°C for 5 minutes. The barcoded library was then purified by using AMPure XP beads (Beckmen, catalog number A63881).

[0118] After library construction, the concentration of the resulting sequencing library was quantified using the Qubit 3.0 Fluorometer dsDNA HS Assay (ThermoFisher Scientific). Size distribution was analyzed in the range of 280 bp to 420 bp using the Agilent Bioanalyzer 2100 (Agilent). Paired-end sequencing was performed using the Illumina system following the protocol provided by Illumina for 2x150 bp paired-end sequencing.

[0119] RNAseq and WES sequencing

[0120] In RNAseq sequencing, a sequencing library focused on mRNA is constructed from total RNA. Poly-A mRNA is purified from total RNA using oligo-dT attached magnetic beads, and then fragmented by a fragmentation buffer. Using short fragments as templates, first-strand cDNA is synthesized using reverse transcriptase and random primers, followed by second-strand cDNA. The synthesized cDNA is then end-repaired, phosphorylated, and 'A' bases are added according to the library construction protocol. Sequencing adapters are then added to both ends of the cDNA fragments. After PCR amplification of the cDNA fragments, 250-350bp targeted fragments are purified. After library construction, the concentration of the resulting sequencing library is quantified using the Qubit 3.0 Fluorometer dsDNA HSAssay (Thermo Fisher Scientific), while the size distribution is analyzed using the Agilent Bioanalyzer 2100 (Agilent). After library validation, clusters are generated using the Illumina cBOT Cluster Generation System (Illumina) equipped with the HiSeq PE Clustering Kit. Paired-end sequencing was performed using the Illumina system following the protocol provided by Illumina for 2x150 paired-end sequencing.

[0121] WES was performed by Wuxi Nextcode Co. Ltd. (Shanghai, China). Briefly, genomic DNA was extracted and broken into an average size of 180-280 bp. DNA libraries were generated according to the paired-end protocol of the Illumina manufacturer. Exons were captured using Agilent's SureSelect Human All Exon V6, and then sequenced by generating 150 bp paired-end reads on the Illumina NovaSeq platform (Illumina, Inc., San Diego, California, USA).

[0122] SNP selection and profiling

[0123] The inventors selected a set of SNPs for identification of human samples based on several criteria: 1) the SNPs are present in exons; 2) the SNPs are located on all 22 autosomes and are sufficiently far apart from each other because chromosomal abnormalities (including deletions and duplications of large chromosomal segments) are common in tumors; 3) the SNPs are present in highly expressed genes; 4) the minor allele frequency (MAF) of the SNPs is approximately 0.5 in three reference populations of the International Haplotype Map Project (i.e., Han Chinese (CHB), Nigeria Yoruba (YRI), and Utah residents of Northern and Western European ancestry in the CEPH collection (CEU)).

[0124] Benchmark samples and data

[0125] Two groups of cell line reference samples were prepared. The first group had 78 samples, 3 pairs of cell lines, including PANC-1 and RT4, MV-4-11 and "LNCaP clone FGC", CAL27 and Raji. Each pair had 26 samples, including two pure cell lines and 3 kinds of replicas (according to cell counting) with 8 mixing ratios (Supplementary Table S2). The second group had 22 kinds of cell lines, which were each polluted by a known second cell line with a small ratio but unclear ratio (Supplementary Table S3).

[0126] Estimated heterogeneity ratio

[0127] There are six informative genotype combinations, using which the heterogeneity ratio can be estimated based on deep NGS sequencing data (Table 11). It exhibits four different nucleotide frequency patterns. Combinations 1 and 2 produce the same pattern, and we use the average formula to calculate the percentage or heterogeneity ratio of the minor component S2. When two combinations are present at equal frequencies, the formula produces an accurate estimate of the ratio, which is a situation that should be approximately estimated when the number of SNPs is large. Combinations 4 and 5 use a similar averaging method. When the heterogeneity ratio is low, sequencing errors may interfere with the inference of the heterogeneity ratio. To alleviate this problem, we use a 2-step statistical procedure. Assuming that at a specified SNP site, the sequencing error is e=0.001 and the sequencing depth is n (n≥500, discarding any SNPs with n<500), the probability of observing k erroneous nucleotides follows the binomial distribution of parameters n and e.

[0128]

[0129] For each n, we calculated the cumulative density function and obtained a threshold h such that the probability of observing more than h erroneous nucleotides in n nucleotides is less than 0.01. In the sequencing data, any low-frequency nucleotides with a read number less than the corresponding threshold h were discarded. We then used the expectation maximization algorithm (R package mclust, version 3.5.3 (Team, RCR: Language and Environment for Statistical Computing, version 3.5.3 (R Foundation for Statistical Computing, Vienna, Austria, 2018)) to estimate the parameters of a Gaussian mixture distribution (with 1 to 3 components) that simulates the distribution of nucleotide frequencies less than the maximum heterogeneity (0.2 was used for all samples in this study). If there is only a single Gaussian component, or the Gaussian component with the smallest mean value accounts for more than 60% of all data points, then the median of all data points is taken as the sample heterogeneity ratio, otherwise the median of the data points in other Gaussian components is taken as the sample heterogeneity ratio.

[0130] Determine the main components in the sample

[0131] Only nucleotides with allele frequencies greater than a threshold (10% for reference samples and 25% for potentially contaminated test samples) are used to determine the genotype of the SNP site. The genotype similarity between the reference sample and the test sample is the percentage of SNPs with the same genotype in the test sample, excluding SNPs with a sequencing depth of less than 500. The main component of the test sample is the reference sample with the highest genotype similarity. If the heterogeneity ratio of the test sample is <10% (or>10%), then the highest genotype similarity must be greater than 90% (or 80%). Otherwise, it cannot be called the main component.

[0132] Determination of minor components in samples

[0133] After estimating the heterogeneity ratio and determining the main component, we determine the minor component of the test sample. For a mixture of the main component and one of the other reference samples (e.g., all cell lines with genomic data), we obtain a mosaic genotype with possible 1 to 4 nucleotides for each SNP site. Nucleotide frequencies are calculated using the heterogeneity ratio. Similarly, we obtain the mosaic genotype of the test sample. Two mosaic genotypes are considered to be the same if they have the same nucleotides and the frequency of each nucleotide is within three times the range. We then calculate the genotype similarity between the test sample and each reference sample merged with the main component. All pairs of genotype similarity sets are then fitted according to the beta distribution with parameters (α, β)

[0134]

[0135] In the equation, Γ(α) is the γ function and x is the genotype similarity. Its parameters are estimated by the package fitdistrplus (version 3.5.3) in R. Based on the fitted beta distribution, we then calculate the probability of observing any genotype similarity greater than a specific value. A quantile-quantile plot with 99% confidence bands is drawn for all observed genotype similarities for visualization. If (1) the reference sample has the highest genotype similarity, (2) its genotype similarity is higher than the 99% confidence limit in the quantile-quantile plot, and (3) its p-value is <1.0E-6 in the fitted beta distribution, then the reference sample is considered a minor component.

[0136] Estimation of the mixing ratio of two cell lines

[0137] The estimation of the mixing ratio of two reference samples is explained using cell lines. Assume that the mixing ratio of two cell lines S1 and S2 is θ for S1 and (1-θ) for S2, where 0≤θ≤1. According to the deep NGS sequencing data, the nucleotide frequencies of all n SNPs in two cell lines can be accurately estimated. For one SNP, its four nucleotide frequencies are represented, totaling 1, which is represented as {A1, T1, G1, C1} for cell line S1 and {A2, T2, G2, C2} for cell line S2. In principle, if the SNP is homozygous, there is one frequency that is close to 1, and if the SNP is heterozygous, both frequencies are close to 0.5. The actual data has some deviations due to sequencing errors and randomness and the polyclonality of the cell line.

[0138] According to the sequencing data of the mixed sample, the actual occurrence of the four nucleotides is represented by x = {n A , n T , n G , n C}. The likelihood of such an observation is

[0139]

[0140] The likelihood P of any SNPi∈(1, 2, ..., n) θ (x i ) can use the observed data x i Calculate the observed data X of all SNPs = {x1, x2, ..., x n The likelihood of} is

[0141]

[0142] The log-likelihood is therefore

[0143]

[0144] The θ that maximizes the likelihood can then be solved for according to stepwise increments of θ. The above procedure can also be applied to a mixture of any two human samples.

[0145] Simulating cell line mixtures for contaminant detection

[0146] Simulations were performed on three pairs of cell lines, including PANC-1 and RT4, MV-4-11 and "LNCaP clone FGC", CAL27 and Raji. All six cell lines were analyzed by deep NGS sequencing to obtain their SNP fingerprints. The computer simulated the mixing of two cell lines of each pair, where the ratio of the first cell line was r, and r took the following values: 0.15%, 0.30%, 0.625%, 1.25%, 2.5%, 5%, 10%, 15% and 20%. For each SNP site, r×n nucleotides were obtained from the first cell line, where n was a random integer from 500 to 5000, and r×n was further assigned to 4 nucleotides (A, T, G, C) according to their frequency in the first cell line. Similarly, (1-r)×n nucleotides were obtained from the second cell line. The ratio was then inverted, thereby completing the symmetrical sampling of the second cell line according to the ratio r.

[0147] Estimation of mouse ratios using RNAseq and WES datasets

[0148] Sequencing reads were mapped in the human (hg19) and mouse (mm10) genomes using the mapping tools STAR (Dobin, A. et al., STAR: An ultrafast universal RNA-seq aligner, Bioinformatics 29, 15-21 (2013)) for RNASeq data and BWA (Li, H. and Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics 25, 1754-60 (2009)) for WES data using default parameters. If a read was mapped only in the human genome, or had fewer mismatches with the human genome than with the mouse genome, it was classified as a human read. Mouse reads were assigned similarly. If a read was mapped in both genomes with a similar number of mismatches (differing by at most 2), the read could not be classified and was discarded. The mouse ratio is the proportion of mouse reads to all deposited reads.

[0149] Example 2

[0150] This example illustrates human sample identification and contamination detection.

[0151] SNP profiling and fingerprinting

[0152] A group of SNPs are selected for identifying human samples, including cell lines, xenografts and organoids (Table 1). SNPs are subjected to spectral analysis by deep NGS sequencing with an average depth of 3000. Each sample has a unique SNP fingerprint, which is composed of the nucleotide consistency and frequency of all SNPs. It should be emphasized that the SNP fingerprint of the cell line can fluctuate between each generation and in the biological sample library due to gene drift and heterogeneity, so in order to better cure, the current SNP fingerprint can be subjected to spectral analysis. According to the relatively low NGS data in depth, SNP fingerprints with reduced accuracy can be produced. In this example, the inventors used RNASeq data to generate SNP fingerprints of 1050 cell lines, which were subjected to spectral analysis by the inventors and CCLE, serving as reference.

[0153] The inventors have described the use of SNP profiling data obtained by deep NGS sequencing to identify, characterize, and detect intra- and inter-species contamination of 217 cell line samples, 220 PDXs, and 31 PDX-derived organoids (PDXO) samples. For cell line samples, the inventors tested a mixture of two cell lines with a known mixing ratio produced by serial dilution and 6 corresponding pure cell lines (Table 7), a mixture of two cell lines with an unknown mixing ratio (Table 8), and 117 unmixed cell lines (Table 9).

[0154] Characterization of human samples

[0155] The identity of the major components of the sample or contaminated sample was determined based on their genotypic similarity to a library of reference samples. Among the 217 cell line samples tested, the genotypic similarity between the same cell lines was always >90%, with an average of 98.6% and a minimum of 91.7% for A-875 cell cultures with 16.7% JEG-3 contamination ( Figure 1A , Table 8). In contrast, the genotypic similarity between unrelated cell lines is almost always less than 50%. Due to a variety of reasons, including mislabeling, contamination, originating from the same patient, one cell line being the parent of another cell line, etc., there are still closely related cell lines or cell lines that exist in the same synonymous group. For example, HCT-15 and HCT-8 may be derived from the same patient; QGY-7701 is contaminated by HeLa derivatives. The genotypic similarity of 16 pairs of such cell lines in the data set ranged from 84% to 96% (Table 10). These cell line pairs can be distinguished, except for almost identical cell line pairs, such as HLE and HLF. For 220 PDX and 31 PDX-derived organoids (PDXO) samples, the genotypic similarity between the same models was 98.0% (87.2-100%) on average, while between different models, the genotypic similarity was almost all less than 50%.

[0156] Estimation of genetic heterogeneity

[0157] If the sample is not contaminated and is a pure monoclonal diploid, then the SNP site is homozygous or heterozygous, and in the deep NGS sequencing data, the observed nucleotide frequency is approximately 1 or 0.5, and the difference only comes from the error and randomness during sequencing. In fact, the cell line may have a small number of clones, be aneuploid or be contaminated (contaminants), so the inventors not only observed that the frequency is far away from 0.5 and 1, but also observed 3 or 4 nucleotides at the SNP site. Such information can be used to estimate the genetic heterogeneity of the sample.

[0158] The dominant clone is the main component of the sample, and a small amount of clones and pollutants are minor components. There are six kinds of genotype combinations with rich information in the main component and the minor component, and the SNP heterogeneity ratio (Table 11) can be estimated using the genotype combination based on the four observed nucleotide frequency patterns. If the SNP site sends one of the four patterns, it is rich in information. Subsequently, using statistical modeling methods, the sample heterogeneity ratio is estimated by individual SNP heterogeneity ratio (see Example 1). Using test samples, the inventors found that the uncontaminated cell line has 107 information-rich SNP sites on average, and the contaminated cell line has 112, which is slightly more. On average, PDX and PDXO models have 156 and 111 information-rich SNP sites, respectively, reflecting the presence of higher genetic heterogeneity and / or mouse contamination in the PDX model.

[0159] Detection and Quantification of Contamination

[0160] The inventors tested sample contamination by combining three analyses. First, contaminated samples can have high heteroplasmy ratios, while uncontaminated samples do not. In the tested samples, 115 of the 118 possible uncontaminated cell lines (97.5%) had heteroplasmy ratios < 2%, and all had heteroplasmy ratios < 3% ( Figure 1B ). In contrast, the inventors observed high heterogeneity ratios for contaminated cell lines, for example, A-875 cell cultures mixed with JEG-3 cells had a 15.5% heterogeneity ratio (Table 8). As shown above, the heterogeneity ratio is proportional to the contamination ratio (percent contaminant) and is therefore a good indicator of contamination. Human tumors dissected from PDX models contain mouse stroma, and the inventors did observe mouse contamination ( Figure 1C ) leads to a higher heterogeneity ratio in PDX tumors ( Figure 1B PDXO is a PDX culture in vitro because mouse cells are much less and usually only in trace amounts ( Figure 1B ) and had significantly smaller heterogeneity ratios.

[0161] The different right peaks of the probability density of the SNP heterogeneity ratios of the samples also indicate contamination ( Figures 2A-2F ). As the contamination and heterogeneity ratios increase, the peak shifts to the right and sometimes splits into two peaks. For uncontaminated cell lines or cell lines with very low contamination ratios (<1%) and very low heterogeneity ratios (<2%), the bimodal / trimodal distribution disappears or only slightly shifts upward.

[0162] Finally, the contaminants can be directly detected by statistical modeling that gives intuitive visualization and strict probability measurement results (see Example 1, Figure 3A). In 94 cell line samples each mixed with another cell line, when the heterogeneity ratio is ≥2%, the inventors can always correctly infer a small amount of contaminant cell lines in the cell line (Figure 3B). When the heterogeneity ratio is 1-2% and <1%, the accuracy drops to about 80% and 50%. Among the 8 missing samples, seven samples are characterized by purity and only one sample is mislabeled as a contaminated cell line. Of course, this type of inference is only feasible when the contaminated cell line is also a cell line with a known SNP fingerprint. The inventors have detected several contaminated cell lines in our biological sample library, an example of which is the cell line "G-292 clone A141B1", which has a high heterogeneity ratio of 7.62% (Figure 3C), and it is contaminated by 6.21% OCI-AML-2 (Figure 3D).

[0163] After identifying the contaminated cell line, the inventors were able to estimate the contamination ratio (i.e., the percentage of the second cell line) using the maximum likelihood method (see Example 1). Simulation studies show that the estimated contamination ratio is extremely close to the known ratio (Fig. 3E). The inventors observed that there is a close linear correlation between the heterogeneity ratio and the contamination ratio (Fig. 3F). Therefore, as discussed before, the heterogeneity ratio is a good estimation indicator of contamination, and is particularly applicable when the contaminant is not a standard cell line. When the contaminant is still in the contaminated sample, it only partially (although sometimes mostly) affects the genetic heterogeneity, and therefore, the contamination ratio is usually less than the corresponding heterogeneity ratio (see Table 8), and a few violations are caused by the data processing method.

[0164] In summary, according to the value and distribution of the heteroplasmy ratio, the heteroplasmy ratio is a reliable measure of human sample contamination. Cell line samples with a heteroplasmy ratio of ≥2% have a high probability of being contaminated, and when the contaminant is also another cell line with SNP fingerprint information, its nature can be inferred and the contamination ratio can be estimated with an unprecedented sensitivity of ≤1%, as measured by the cell or DNA mixing ratio (Tables 7 and 8).

[0165] Example 3

[0166] This example illustrates the characterization of a mouse tumor model.

[0167] A panel of mouse SNPs (see Table 2) was selected for identification of 32 syngeneic mouse tumor models commonly used in preclinical immunomodulatory drug development, including 4T1, A20, B16-BL6, B16-F0, B16-F1, B16-F10, C1498, Colon26, CT26WT, E.G7-Ova, EL4, EMT6, H22, Hepa1-6, J558, J774A1, JC, KLN205, L1210, L5178-R, LLC, MBT2, MC38, MPC-11, Neuro-2a, P388D1, P815, Pan02, Renca, RM1, S91, and WEHI164. Most models had 6 unique SNPs. Colon26 and CT26WT are mouse colon adenocarcinoma models derived from BALB / c mouse strains, each of which has 12 SNPs and 6 common SNPs, a total of 18 unique SNPs. B16-BL6, B16-F0, B16-F1 and B16-F10 are mouse melanoma cell lines in the C57BL / 6 mouse strain and are all derived from B16, so they share high genetic similarity. Specifically, B16 is the parent strain of B16-F0, which is in turn the parent strain of B16-F1. B16-F10 is the 10th generation of B16-F0 and is a B16-BL6 46 The inventors first assigned test cell lines in this group using 7 common SNPs, then assigned B16-BL6, B16-F0 and B16-F10, each with 6 unique SNPs, and when none of the 18 SNPs were observed, assigned B16-F1 as the test cell line. The identification of these models achieved 100% accuracy.

[0168] Example 4

[0169] This example illustrates human-mouse cross-species contamination detection.

[0170] The inventors compared the human hg19 and mouse mm10 genomes and identified a set of 100-300bp segments (see Table 3), so each segment diverged significantly (31-97% sequence similarity) between humans and mice due to insertions, deletions and point mutations, but had consistent flanking sequences, enabling the design of universal primer pairs. After NGS sequencing, the inventors separated human and mouse reads, calculated the mouse ratios of all segments, and took the median of these ratios as the mouse ratio in human-mouse mixed samples. This method showed extremely high accuracy in a set of benchmark samples in which mouse and human DNA were mixed by serial dilution (Figure 4A). The inventors also developed a method for estimating mouse content using RNAseq and WES data (see Example 1). The inventors compared the three methods for estimating mouse ratios in 220 PDX and 31 PDXO models (Figures 4B-C). DNA (for WES and deep NGS sequencing) and RNA (for RNAseq) were extracted and the same samples of the model were sequenced to remove sample bias. PDXO models typically have low mouse content. Among PDX models, the mouse ratio was accurately estimated highest based on deep NGS sequencing data, followed by RNAseq and then WES. This is mainly because the exon capture kit used in WES is designed to enrich human exons and has low hybridization affinity for homologous mouse exons. RNAseq uses a polyA enrichment scheme that does not have species preference, but there is great spatiotemporal variability in gene expression in human tumors and mouse stroma of PDX. The inventors did observe a very strong quadratic relationship between the mouse ratio between deep NGS sequencing data and WES data (R = 0.96, Figure 4D), but the linear correlation between deep sequencing data and RNASeq data was much weaker (R = 0.62).

[0171] Example 5

[0172] This example illustrates the detection of mycoplasma in a sample.

[0173] The inventors used a pair of universal primers to detect all mycoplasma species, and used 11 pairs of primers to detect 11 species of Mollicutes, including Acholera bovis, Mycoplasma arginini, Mycoplasma fermentans, Mycoplasma genitalium, Mycoplasma hominis, Mycoplasma hyorhinis, Mycoplasma oralis, Mycoplasma pneumoniae, Mycoplasma salivarius, and Ureaplasma urealyticum, which have proven effectiveness (MollaKazemiha, V. et al., Cytotechnology 61, 117-24 (2009)). The inventors identified a cell line contaminated with mycoplasma in a biological sample library by a deep NGS sequencing method and then verified it using a mycoplasma detection kit.

[0174] Example 6

[0175] This example illustrates population structure analysis and gender determination.

[0176] In a group of SNPs for identifying human samples, 143 are characterized by the International HapMap Project (International HapMap Alliance (International HapMap, C.), International HapMap Project, "Nature" 426, 789-96 (2003)). The inventor uses fastSTRUCTURE (Raj, A., Stephens, M. & Pritchard, JK, "Genetics (Genetics)" 197, 573-89 (2014)) to perform population structure analysis on three reference populations: Utah residents with Northern and Western European ancestry in the Han Chinese (CHB), Nigeria (YRI) and CEPH collection (CEU). All 406 individuals are clearly assigned according to high probability. The inventor then carries out spectral analysis to 423 PDX models derived from East Asian patients and 634 PDX models derived from Western U.S. patients. All East Asian PDX models have dominant CHB composition, with only one exception. Most of the western PDX models have mainly CEU composition, and the rest have mainly CHB or YRI composition or a mixture of two or three in the reference population. The inventors also used 3 SNPs on the Y chromosome for gender inference (Table 3), which was always accurate except for tumor samples with Y chromosome disappearance.

[0177] While the present disclosure has been particularly shown and described with reference to certain embodiments, some of which are preferred embodiments, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present disclosure as disclosed herein.

[0178] References

[0179] 1. Identity crisis, Nature, 457, 935-6 (2009).

[0180] 2. American Type Culture Collection Standards Development Organization Working Group, ASN, Cell line misidentification: the beginning of the end, Nat Rev Cancer, 10, 441-8 (2010).

[0181] 3. Capes-Davis, A. et al., Match criteria for human cell line authentication: where do we draw the line?, Int J Cancer 132, 2510-9 (2013).

[0182] 4. Gartler, SM. Apparent Hela contamination of human heteroploid cell lines. Nature, 217, 750-1 (1968).

[0183] 5. Lacroix, M., Persistent use of "false" cell lines, Int J Cancer 122, 1-4 (2008).

[0184] 6. Lorsch, JR, Collins, FS and Lippincott-Schwartz, J. Cell Biology, Fixing problems with cell lines, Science 346, 1452-3 (2014).

[0185] 7. Fusenig, NE, Capes-Davis, A., Bianchini, F., Sundell, S., and Lichter, P. The need for a worldwide consensus for cell line authentication: Experience implementing amandatory requirement at the International Journal of Cancer. PLoS Biol, 15, e2001438 (2017).

[0186] 8. Yu, M. et al., A resource for cellline authentication, annotation and quality control, Nature 520, 307-11 (2015).

[0187] 9. Bian, X., Yang, Z., Feng, H., Sun, H., and Liu, Y., A Combination of Species Identification and STR Profiling Identifies Cross-contaminated Cells from 482 Human Tumor Cell Lines, Sci Rep 7, 9774 (2017).

[0188] 10. Horbach, S. and Halffman, W., The ghosts of HeLa: How cell line misidentification contaminates the scientific literature, PLoS One 12, e0186281 (2017).

[0189] 11. de Maagd, RA et al., Identification of Bacillus thuringiensis delta-endotoxin Cry1C domain III amino acid residues involved in insect specificity, Appl Environ Microbiol 65, 4369-74 (1999).

[0190] 12. Azari, S., Ahmadi, N., Tehrani, M. J., and Shokri, F., Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran, Biologicals 35, 195-202 (2007).

[0191] 13. Wu, ML et al., A 2-yr service report of cellline authentication, In Vitro Cell Dev Biol Anim 49, 743-5 (2013).

[0192] 14. Masters, JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2, 315-9 (2002).

[0193] 15. MacLeod, RA. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83, 555-63 (1999).

[0194] 16. Cosme, B. et al., Are your results valid? Cellular authentication a need from the past, an emergency on the present, Animal Cell Development and Biology in vitro 53, 430-434 (2017).

[0195] 17. Ye, F., Chen, C., Qin, J., Liu, J., and Zheng, C., Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China, FASEB J 29, 4268-72 (2015).

[0196] 18. Freedman, LP et al., The culture of cell culture practices and authentication--Results from a 2015 Survey, Biotechnology, 59, 189-90, 192 (2015).

[0197] 19. Nims, RW and Reid, Y. Best practices for authenticating cell lines. In vitro Animal Cell Development and Biology 53, 880-887 (2017).

[0198] 20. Almeida, JL, Cole, KD and Plant, AL. Standards for Cell Line Authentication and Beyond. PLoS Biology 14, e1002476 (2016).

[0199] 21. Almeida, JL et al., Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines, PLoS One, 14, e0218412 (2019).

[0200] 22. Zaaijer, S. et al., Rapid re-identification of human samples using portable DNA sequencing, Elife 6 (2017).

[0201] 23. Yousefi, S. et al., A SNP panel for identification of DNA and RNA specimens, BMC Genomics, 19, 90 (2018).

[0202] 24. Jobling, MA and Gill, P., Encoded evidence: DNA in forensic analysis, Nat Rev Genet 5, 739-51 (2004).

[0203] 25. Sanchez, JJ et al., A multiplex assay with 52 single nucleotide polymorphisms for human identification, Electrophoresis 27, 1713-24 (2006).

[0204] 26. Didion, JP et al., SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy, BMC Genomics 15, 847 (2014).

[0205] 27. Liang-Chu, MM, et al. Human biosample authentication using the high-throughput, cost-effective SNPtrace(TM) system. PLOS ONE 10, e0116218 (2015).

[0206] 28. Pengelly, RJ et al., A SNP profiling panel for sample tracking in whole-exome sequencing studies, Genome Med 5, 89 (2013).

[0207] 29. Morgan, AP et al., The Mouse Universal Genotyping Array: From Substrains to Subspecies, G3 (Bethesda) 6, 263-79 (2015).

[0208] 30. Castro, F. et al., High-throughput SNP-based authentication of human cell lines, Int J Cancer 132, 308-14 (2013).

[0209] 31. El-Hoss, J. et al., A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts, Oncotarget 7, 60475-60490 (2016).

[0210] 32. Ruitberg, CM, Reeder, DJ and Butler, JM, STRBase: a short tandem repeat DNA database for the human identity testing community, Nucleic Acids Res 29, 320-2 (2001).

[0211] 33. van der Meer, D. et al., Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models, Nucleic Acids Res 47, D923-D929 (2019).

[0212] 34. Tuveson, D. & Clevers, H., Cancer modeling meets human organoid technology, Science, 364, 952-955 (2019).

[0213] 35. Day, CP, Merlino, G. and Van Dyke, T. Preclinical mouse cancer models: a maze of opportunities and challenges. Cell 163, 39-53 (2015).

[0214] 36. Guo, S. et al., Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines, Cancer Res 76, 4619-26 (2016).

[0215] 37. Khaled, WT and Liu, P. Cancer mouse models: past, present and future. Semin Cell Dev Biol 27, 54-60 (2014).

[0216] 38. Li, QX, Feuer, G., Ouyang, X. and An, X., Experimental animal modeling for immuno-oncology, Pharmacol Ther, 173, 34-46 (2017).

[0217] 39. Chao, C. et al., Patient-derived Xenografts from Colorectal Carcinoma: A Temporaland Hierarchical Study of Murine Stromal Cell Replacement, Anticancer Res 37, 3405-3412 (2017).

[0218] 40. Fasterius, E. and Al-Khalili Szigyarto, C. Analysis of public RNA-sequencing data reveals biological consequences of genetic heterogeneity in cell line populations. Sci Rep 8, 11226 (2018).

[0219] 41. Ghandi, M. et al., Next-generation characterization of the Cancer Cell Line Encyclopedia, Nature 569, 503-508 (2019).

[0220] 42. Vermeulen, SJ et al., Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet 107, 76-9 (1998).

[0221] 43. Rebouissou, S., Zucman-Rossi, J., Moreau, R., Qiu, Z., and Hui, L., Note of caution: Contaminations of hepatocellular celllines, J Hepatol, 67, 896-897 (2017).

[0222] 44. Barretina, J. et al., The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drugs ensitivity, Nature 483, 603-7 (2012).

[0223] 45. Bairoch, A., The Cellosaurus, a Cell-Line Knowledge Resource, J Biomol Tech 29, 25-38 (2018).

[0224] 46. ​​Molla Kazemiha, V. et al., PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experience, Cytotechnology, 61, 117-24 (2009).

[0225] 47. International HapMap Consortium, International HapMap Project, Nature, 426, 789-96 (2003).

[0226] 48. Raj, A., Stephens, M. and Pritchard, J. K., fastSTRUCTURE: variational inference of population structure in large SNP data sets, Genetics, 197, 573-89 (2014).

[0227] 49. Masters, JR et al., Short tandem repeat profiling provides an international reference standard for human cell lines, Proceedings of the National Academy of Sciences of the United States of America 98, 8012-7 (2001).

[0228] 50. Hideyuki Tanabe, YT, Daisuke Minegishi, Miharu Kurematsu, Tohru Masui, Hiroshi Mizusawa, Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1 / T24, Tiss. Cult. Res. Commun. 18, 329-338 (1999).

[0229] 51. Team, RCR: A language and environment for statistical computing, version 3.5.3 (R Foundation for Statistical Computing, Vienna, Austria, 2018).

[0230] 52. Dobin, A et al., STAR: ultrafast universal RNA-seq aligner, Bioinformatics 29, 15-21 (2013).

[0231] 53. Li, H. and Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-60 (2009).

[0232] Table 1. Human SNPs

[0233]

[0234] Table 1. Human SNPs

[0235]

[0236] Table 1. Human SNPs

[0237]

[0238] Table 2. Mouse SNPs

[0239]

[0240] Table 2. Mouse SNPs

[0241]

[0242] Table 2. Mouse SNPs

[0243]

[0244] Table 2. Mouse SNPs

[0245]

[0246] Table 2. Mouse SNPs

[0247]

[0248] Table 2. Mouse SNPs

[0249]

[0250] Table 3. Human Y chromosome SNPs

[0251]

[0252] Table 4

[0253]

[0254] Table 5

[0255]

[0256]

[0257] Table 6. Mouse genome sequences homologous to humans

[0258]

[0259] Table 6. Mouse genome sequences homologous to humans

[0260]

[0261] Table 7. Serial dilution cell line pair identification and contaminant detection*

[0262]

[0263]

[0264] *: Average of each cell line mixture with 3 technical replicates, except for cell lines that were not mixed

[0265] **: Percentage of minor cell lines based on cell counts

[0266] ***: Genotype similarity is shown in brackets

[0267] ****: The similarity of chimeric genotypes is shown in brackets

[0268] *****: Probability of incorrect inference of minor components

[0269] Table 8. Cell line mixture identification and contaminant detection

[0270]

[0271]

[0272] *: Primary cell line: Form of secondary / contaminating cell line

[0273] **: Genotype similarity is shown in brackets

[0274] ***: Mosaic genotype similarity is shown in brackets

[0275] ****: Probability of incorrect inference of minor components

[0276] Table 9. Identification of cell lines

[0277]

[0278]

[0279]

[0280]

[0281] * Genotype similarity is shown in brackets

[0282] Table 10. Genotypic similarity of related cell lines

[0283] Cell lines tested Related cell lines Genotype similarity Hela SMMC7721 0.8431 Hela BEL7402 0.8529 Hela QGY7701 0.8657 Hela QGY7703 0.8683 SW480 SW620 0.8852 NCIH1993 NCIH2073 0.8932 OCUM-2M OCUM2D 0.9 143B HOS 0.9179 SR SR786 0.9235 SJCRH30 RH30 0.932 143B KHOSNP 0.9563 Hep3B HEP3B217 0.9573 HCT-8 HCT15 0.9608 HepG2C3A HEPG2 0.9622 HCCLM3 MHCC97H 0.9626

[0284] Table 11. Six informative genotype combinations for estimating heterogeneity / contamination ratios*

[0285]

[0286] *: In a mixed sample, S1 is the main component and S2 is the minor / contaminating component. Each combination uses a specific nucleotide to represent a class of combinations, for example, the first combination indicates that both are homozygous genotypes with different nucleotides. In the S2 ratio calculation formula, the nucleotide represents its count (total number of reads) in the NGS sequencing data.

[0287] **: Combinations 1 and 2 could not be distinguished using the observed NGS data, so 1.5T / (A+T) was used for both.

[0288] **: Combinations 4 and 5 could not be distinguished using the observed NGS data, so 1.5G / (A+T+G) was used for both. Sequence Listing <110> Crown Biotech (Suzhou) Co., Ltd. <120> Methods and compositions for identifying tumor models <130> 078272-8002CN01 <150> PCT / CN2019 / 077750 <151> 2019-03-12 <160> 544 <170> PatentIn Version 3.5 <210> 1 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 1 aatcacagcc aatattctca agttccaaga naccgatggc aaacacctgc tgccaaagat 60 c 61 <210> 2 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 2 gcagagccgc cctctccgcc actgtccccc nccacgagcc ccccttccac ctggaccggg 60 a 61 <210> 3 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 3 gtgcttgaac tcaaacatgt tcctctgcac naaagtcttg cggatcttct ggttggtcca 60 g 61 <210> 4 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 4 caatactcgc cccaccgtgt gataggctct nctggtaact ttaatgtatg tggggcaacc 60 a 61 <210> 5 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 5 ctaaatctgt tgaagttacc tccggagtcc natctagaaa gcatcatagt cttcagagtc 60 c 61 <210> 6 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 6 agtagtccta ttagcccaga ggcgatgtct ntcatgatgt ccacgtcact gtagtatggt 60 c 61 <210> 7 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 7 ggctgcaacg gggcgggctc tgctgcgtca ncacatggac atcactggag aggaaaaccc 60 a 61 <210> 8 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 8 gcagagctcc ggctgcgatg gggccaaatc ntccttaaga acgaccacca ggaagatttc 60 t 61 <210> 9 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t, a or c <400> 9 ggctaacatg tgcagctctc tcttcagacg ngaagctctc tgcatgatcc ccaagtagaa 60 g 61 <210> 10 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 10 tctggggtga acatattcta gccctgaaga ntctgaagtt agacaagatg gttggctggc 60 t 61 <210> 11 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 11 ggagctggca gctaccagca cactgcctcc nccgtcaata aaggcactga tggtctccac 60 g 61 <210> 12 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 12 attgagcttg atgggcaggt ctctgtgtga ntgtacccat tttgcatatg caggatacat 60 t 61 <210> 13 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 13 attccatgcc ctcaaacttc accttttttt ntcttgctct tccttctcta ttttgtggga 60 c 61 <210> 14 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 14 caaggaccag gcaacagcag agcagcctta ngcatcttgg aagatcccga ggttagattc 60 t 61 <210> 15 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 15 gtcggtccac tccgcttggt tatctgcttc naccaaatta gtacctggga aggaaaaaga 60 a 61 <210> 16 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 16 ccacgcgctc cagtagcggc ccgtcctcgc ngggccgcaa acatggcccg acggctgcta 60 g 61 <210> 17 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t, a, or c <400> 17 acatacctgc tctgtcttca tgtggaactc nttgagctca tcctctgtga ggggaaggca 60 a 61 <210> 18 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 18 tgggtccccc caggaagaga gggcaggtga nttagaatgt ttctccccga agacaggacc 60 t 61 <210> 19 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 19 tgtcaatcat agaccaacgg gcatattcca ngattaaaag ccgtacatct ctgtacagag 60 g 61 <210> 20 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 20 tgaaccgtgt tctttccagg aacctgttgg nccagttggt ttcaagccag agacattcag 60 a 61 <210> twenty one <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> twenty one acgacggagt cttttccttt cttgtcgatg nagtttctca gcctcctgtt gcttcttctg 60 c 61 <210> twenty two <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> twenty two ctctcggcga ggtggcgcca cgttttcaca ncagccttct cagagttgta cgtggagctg 60 a 61 <210> twenty three <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> twenty three tcttctagag gcagggagct caccaccctt ncagtgtcca acttctttag taattacaca 60 c 61 <210> twenty four <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or does not exist <400> twenty four tgtctgggag gcagccacag agctggctgc nggctccctg cccacccagc gctactctcc 60 t 61 <210> 25 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 25 tctttcagat ccctcccacc tcctgaaatg ntctaattaa aaacatccag gcttgtatag 60 a 61 <210> 26 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t, a, or c <400> 26 aataaatact attaccaacc tctttcgaat nctagcatta aacagtggtg cctcaaaacg 60 t 61 <210> 27 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 27 acacgcactt caatggggca gggtcccccc nagatggagt gaaatgctcc cctggaggac 60 c 61 <210> 28 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 28 atcctcctca tcctcctcac tgtcatcatc ntcctcttca tcactgtctt ccttcttggc 60 a 61 <210> 29 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 29 gacttgtcgg caccaggaag agagccaggg nacttcaatc cagaaagcag agaagatacc 60 a 61 <210> 30 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 30 ggggacagat ggcctttctc gggtgtgctt ngaggagaaa ctgtacgaat gaagtgagcc 60 g 61 <210> 31 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 31 gggaaggccc acgtctggct gtttacacca ntctagggaa aaattctgcc aagaaagaac 60 c 61 <210> 32 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 32 cagctgtgtc agctctaccc ccgactgaaa ntgctggcat ttggagcaaa gccggattcc 60 a 61 <210> 33 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 33 gttgacagtt tcagtgtaag ttcgagcctt nggagggttg gggaccccag atgaagcaga 60 a 61 <210> 34 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 34 tggtctggtg accacaccta gaacaactgc nttaagatta aataatgttg gatacagctt 60 g 61 <210> 35 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 35 ccggatccac tggtcctcct tgtccctcac ntcgaagtac ccactgccat ccaggatgta 60 g 61 <210> 36 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 36 accctttttt gttttttaac agacttgtaa ngaaaccaag gatgttagtg ctctgacaaa 60 a 61 <210> 37 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 37 tgtttcttaa tggtgtatgg attcttcaac ntatgacaga acctgcattt aaaagcacat 60 a 61 <210> 38 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 38 aaaagagttg ttagaaaaaa agccgtggca ncttcagggg gaagtgacag cacagaagag 60 g 61 <210> 39 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 39 atttcagggt gatgctggtt tgactggacg naaaatcatt gtggacactt atggcggttg 60 g 61 <210> 40 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 40 ctcatagctc cgtcacacac atgtacaaga nggtgaagca ggtggtatca cacaacaaat 60 t 61 <210> 41 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 41 tatattcctc ttgctccaga acaaacatgt nccaattgaa gaattgttgt aatttttcat 60 t 61 <210> 42 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 42 caaggagcaa atagtttctttttcttacgg nacttcgcta ggaatttaag cgcctggaag 60 a 61 <210> 43 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 43 caaaaacttc gaccgagaga ttggccacaa naaccccagg tgagagccag gcccaaggcc 60 t 61 <210> 44 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 44 catatttgct gccatgtgaa ataaggagaa ntgactgaat gttgacagca acattggaga 60 a 61 <210> 45 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 45 ccccagtctc cccacaggta tgcctataac ntaagtctaa aggaggtgat gcaggtactg 60 a 61 <210> 46 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 46 gaaattcaga atatccagta ctcttacccc ngcaatgtct gtaatcactt tctctgtgat 60 c 61 <210> 47 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 47 tgatgacata tttgataaac ttaaagaggc ngttaaggaa gaaagtatta aacgacacaa 60 g 61 <210> 48 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 48 agtgtatcac cagagtcctg gacaggctcc ntacccggga ccccagcagc cttcataccc 60 c 61 <210> 49 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 49 cagcttgggc agtcaggttt ggggccttcc ngggtggccg gggagagggg gctgtgggga 60 a 61 <210> 50 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 50 ggcagcggaa gtgtgtctgc aggtggtcaa ngtcggccca actgagctcc cccacaggtc 60 g 61 <210> 51 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 51 cgttggcacg ctccagccgg gtgcggccct ncccagcgcg cccagcgggt gccagctccc 60 g 61 <210> 52 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 52 ggctacagga attctctgga attttttact ntgcttgctc agagaagagg tatgcaccaa 60 a 61 <210> 53 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 53 ccccatggct cctggtaact acctgatcag ngtcaaatac ggtgggccca accacatcgt 60 g 61 <210> 54 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 54 tcacccaaaa agtaagttca cttacgccaa ntgtgaactt gaacttgaat gggggtccct 60 c 61 <210> 55 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 55 caattctgtg ttcaccctca ccctgcaggc nggcctctca gccatcaaga caccgtatcc 60 t 61 <210> 56 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 56 tgcaatggtt tcaaaatcat cttgatcccc naaaaaagag atattcaaag aaagatgctt 60 g 61 <210> 57 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 57 cttgaggaag cagtccttat acctcaagtt ngaccccctc ctgagggaca gtcctggtag 60 a 61 <210> 58 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a, c, g, or t <400> 58 cttagcgcat tcattacaag ggaacaaggc nacatacata ctacagcctt tcacatcggt 60 c 61 <210> 59 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 59 agccgatcta ggaattgtac ttttgcttcc nggcttttcc gcctgtcttg acagttcttt 60 c 61 <210> 60 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 60 tagtgctatt cccacccgta ccatgcattt ngagaagcac tggagattac tggaaagtat 60 g 61 <210> 61 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 61 catacctggt ctcatccgaa ccctgcggat ntatttttca cccaagaaat ttcggatttc 60 a 61 <210> 62 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 62 gagagactgt agcacttttc tcagaactag ngagacgggc attgtggatc aggttatggt 60 a 61 <210> 63 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 63 gtcactgact ttgatgattg gctcattttt nctaagatcc catacagtgg cccggccact 60 g 61 <210> 64 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 64 tctcacctgc acagatgagg agagttcaca nttagccttt tcagcagctt cccgtaccct 60 c 61 <210> 65 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 65 ctacatctgt gtctctagtg cccccatcaa nagtcttctg ctggtggatg agaatgttct 60 g 61 <210> 66 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 66 gtcctcggag tggaagcggc acatgtcatg ntgggaggcc tggtatggct tgaagacctc 60 g 61 <210> 67 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 67 ctggatgaca tccaggctgg cagccccagc ncgccccaca ttgatggtca caggctttac 60 a 61 <210> 68 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 68 tccaccacca cctggctctc ctgtggggct nttccgaggt gtgtgtctcc gcctgctttg 60 g 61 <210> 69 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 69 aaagtttgac aggcagggac gggggcagat ngccttcgac gacttcatcc agggctgcat 60 c 61 <210> 70 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 70 aagctggggat ttggggtcat tccaatcctg nttcaaaatg aactcctgtg gaagtccccc 60 a 61 <210> 71 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 71 ataaagtgag gaaaacacgg agttgatgca naagccccaa catccaacct cgactcctct 60 t61 <210> 72 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 72 tgcatagaca ctccccttca gtgggaaaac nccctgaaga cagcagaggc aacctggata 60 t 61 <210> 73 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 73 tcgatgtagc aacagcttga agacaaaagg ngaagagatc tgtaagagaa ttaactagtt 60 a 61 <210> 74 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 74 cactttcacc attacaggcc atgctgagac naagcagctg acagaaatgc tacccagcat 60 c 61 <210> 75 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 75 agtaaatgtg agcgaattgg gccttgtgac ncaaggaggc aaagttattt ggggtaagtg 60 a 61 <210> 76 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 76 gcacgaaaac tgtttatgga atccagtcga ngttcaggca ccgcgcgatg aacgcaaaca 60 t 61 <210> 77 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 77 gatcacatta aagagctagt agatgactca ntaaataatg tcaggaagga cgatccaaca 60 c 61 <210> 78 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 78 aaaggggaaa gcagatgctg gaaaggatgg naacaaccct gcaaaaaacc gagatgcctc 60 t 61 <210> 79 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 79 gcctcaggag cagggatggg ggtggtacac ngaggaaagc agtgagaagc acgcagggcc 60 g 61 <210> 80 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 80 tggtagctgg aaatagtcct aagaaacaag nttctagacc acctatccaa aatgcatgtg 60 t61 <210> 81 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 81 gggttttatg accagcagcg agggtgctta ngcccacagc atgcacatcc gcatccacag 60 c 61 <210> 82 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 82 ctaaaacaag ctgtttttac cttcaggagc ntctgcatca catctctttg gcacagaaag 60 g 61 <210> 83 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 83 cagggagctg atggcagtac acttaaaaac nctcctcaaa gttcaaactt agatttcaga 60 t61 <210> 84 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 84 gatgaaagga tgctgctgag gaattctgga ntccgtacta ggaaatttta agaaactttg 60 t61 <210> 85 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 85 taagaagaga attcacatct ttctgttcta nctggtattc ctgcattatt ttctcagcag 60 t 61 <210> 86 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 86 tgcccctcct ggagaattta atgaggtttt naatggtgag tgtttgattt ataacactag 60 g 61 <210> 87 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 87 atctgctagc tacaagcccg tgtttgtgac ngagatcact gatgacctgc acttctacgt 60 g 61 <210> 88 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 88 gtctgtaagt tgtttgtgtg tcactgtgac ngctcccacg gttgtttcct ttggcaaacc 60 t 61 <210> 89 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 89 tgtagcagtt gcttcttcct gtttcaatgg nttgctatgt tcatatctaa gaaaaaattc 60 a 61 <210> 90 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 90 gttctcctcc agctctagcc gcgtcttcac ntactgatca taattaccct gcatggaaat 60 g 61 <210> 91 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 91 tcttgatggt gctgtttgga cccgagttac ngagctggaa gcgctggctc acagtcatgt 60 c 61 <210> 92 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 92 catgtcctgc aggagggact ggggactctt ntccacgtgg tcgctgctct cggccagcgt 60 g 61 <210> 93 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 93 tgtgcagagg tggatgaggt cttgtgaaaa nctggctcct tttaacacgg ccctcaagct 60 c 61 <210> 94 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 94 cgttaagtgc tggatatact tggcttgcac nggacacctt ttacggaggg attccggcaa 60 c 61 <210> 95 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 95 gatctcgtgg gcttcgctgt aggccttctc ngaggactcc accaccgtcg cccttttctc 60 t61 <210> 96 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 96 cagtgcggtt ggtgagcagc tcctgcccac ngtcgagcac ctccagctgg agctggatca 60 g 61 <210> 97 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 97 caagatcaag gactgtcctt ggtatgaccg nggcttctgc aagcacggta ggtgccaggg 60 t61 <210> 98 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 98 gacttgcatc tttacccact agacttctgc nctgacccag gggctggagc gaatcccaga 60 c 61 <210> 99 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 99 tgttgacata gttgaccagc tcatccgaca ngggatggaa agagggcctg ctccgggcat 60 t61 <210> 100 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 100 tcttttggtg aggcacatgt atcgaattta nggattacag ttattgatgg aggacacatg 60 g 61 <210> 101 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 101 ctggatagag cgcacacagg cctccagctg ngccatgtcc gtctcatcat cccactgtgg 60 g 61 <210> 102 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 102 gcaggacacc accttgcggg cgcccacctc naaggccgag tgcaggacgt tgtcgttcat 60 g 61 <210> 103 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 103 atgcaaagaa cttccaggcc ctaaagaaag nagacggact gccaaagacc tttgggaagt 60 t 61 <210> 104 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 104 tgtgttgtag gagtgtgggg ctgattgtgc naagttccag aagagtgagc tagaattcaa 60 g 61 <210> 105 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 105 atctttctct tcccagcggc agagcataaa ntccttgttg ggcttatcac attgagctcc 60 a 61 <210> 106 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 106 accccagcga tggtcgtgcc agttttccgg ncctttggaa gcttgtatcc cctctttgca 60 a 61 <210> 107 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 107 gatgccctgc cagagtagca ccttcccgtc ngtggccaca ctcagcacct ggaagcggtg 60 g 61 <210> 108 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 108 gtctgctgct tctgctgccc cctcctcctc naagcagccc gctgctgaca cagaggcatc 60 a 61 <210> 109 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 109 ccgcttcttg aggacaaagt catagttggc ngtagagttc atggcataga agacgttggc 60 g 61 <210> 110 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 110 ggcgttctgc ttcaccacgg tcaggctggc nccctggccg caccgcaggg cttcattctc 60 t61 <210> 111 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 111 aaggtttgac tggaatgaaa actgggacga naggtaccta ttttaagata agtatgacac 60 t61 <210> 112 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 112 agaattgaaa aaggcttata ggaaactggc nttgaagtac catcctgata agaacccaaa 60 t61 <210> 113 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 113 tacctgagga tttactccag caagagcctg nagcatctgc tgaataaact gctgatgtcc 60 a 61 <210> 114 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 114 tctgcctgat gaagatctgg cttcctttca ntggagttta cttggtccag aacatccact 60 a 61 <210> 115 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 115 agttggtggg gcaactcttc actgtgcttg nacctgggct ggggcaggat cctgaacctc 60 t61 <210> 116 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 116 catcactgcc ctggcccacc tccgtgctgc ngtcctgtat gtgatggatt tgtctgagca 60 g 61 <210> 117 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 117 gaaacttaca agactccgct tccaagcttc ntgtatctta aaggagaaaa aagaatagct 60 t61 <210> 118 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 118 ttcaaatggc tttgcatttg catgtttcag ngctagagcg taggaataga ccctggcgtc 60 c 61 <210> 119 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 119 aggaagagaa ttttcgctca agttgttgta ngtcaagtcc agaacctcaa gagctggcag 60 g 61 <210> 120 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 120 ctaccagctg atcaatctgt ccaattttta nttcagataa tccaaggtcc cttaagttaa 60 g 61 <210> 121 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 121 ttctcccatg gctcagaccc caccctgcca nctgcccaat atcccaggag tcactagccc 60 t61 <210> 122 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 122 gaaccgctgg cggaacatga tccgcacttc ngcatggcca gcacgagtca gcacatcagt 60 g 61 <210> 123 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 123 gaacgagctg atatcgaatg gagaaggtga nggcactgcc caggatctgc aaggagaaat 60 g 61 <210> 124 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 124 tcatggagtc tccaagaact gctaaaggag naaggggtaa aggagttctc tacgttccca 60 t61 <210> 125 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 125 tttctgttga tgttcaaatt cttccttctc ngcagtctga ggaagagaaa aaggaattac 60 t61 <210> 126 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 126 aatatctccc tggacggggc gtttctactc nctgctggat ccctcttatg ctaagaacaa 60 c 61 <210> 127 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 127 ttcgtggtct tcaaaccgca ccccaagctc nggcaggatg ttgtcccgca gggcatcgct 60 g 61 <210> 128 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 128 tttgaagact gggatgtatt atttaaggac nagaccagcg gctaatccaa tccagttcac 60 t61 <210> 129 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 129 gcctcactag actcgaggcc tgagctccgg ntctccactt ccctccggtt tgtggctctg 60 a 61 <210> 130 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 130 ggagtcagcc gcctacctgg ccctcttgac ncggggcctg cagagactct accaggtgag 60 c 61 <210> 131 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 131 tcatcctact ctcatcacac actggatgcc ntatggatcc ctctacaatg tactacatga 60 a 61 <210> 132 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c, a or t <400> 132 tctcaccttc ctcctcctcc agccgccctt naccgcagag aaccggaaga aaaccatgga 60 t 61 <210> 133 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 133 tcccaatgct attgccaggc aagtaaacac ngaagctgtg aaaagaagaa actgtgttat 60 a 61 <210> 134 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 134 taaatgttgt gtttaggtgg aagaagagcc ngaagaagaa cctgaagaga cagcagaaga 60 c 61 <210> 135 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 135 ccctcagact cggccgatgg gtcatttttc ntgtatattt tctcttgatt cccctccttc 60 a 61 <210> 136 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 136 ccagttggga tggacaaaac ccaccaagat ncagattgaa gctattcctt tggccttaca 60 a 61 <210> 137 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 137 atctgccacc gtggcaaggt acaagccttc nggagagaag cacacagatc tcagtgagct 60 a 61 <210> 138 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 138 ccagttggga tggacaaaac ccaccaagat ncagattgaa gctattcctt tggccttaca 60 a 61 <210> 139 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 139 ggtcaggcaa ggggtcagag gcaccctggg nggtttgtac tgggctgaaa tccagtcccc 60 c 61 <210> 140 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g, a, c, or t <400> 140 tccacctgat atccagaccc cagagtcatc ntctgtgaag gaagaactca ttccccaaga 60 t61 <210> 141 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 141 ctgtagccca atgggaattg cctgacgctg nataggtgtt ggttcctgca gtgaccccaa 60 g 61 <210> 142 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 142 gagagattgg gtttttacct ccagcaagaa ntctgagaca tcatgtagac acatgatcag 60 a 61 <210> 143 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 143 taacatggct ctctctgtct tacagggcaa ngcaatctat aatctccttc cagatatcat 60 c 61 <210> 144 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 144 cttcaacagc gacacccact cctccacctt ngacgctggg gctggcattg ccctcaacga 60 c 61 <210> 145 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 145 gcgatctgcc atgagagcag tagcagcact nctaaccatt ccagaagcag agaagagtcc 60 a 61 <210> 146 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 146 gatggcatca accaccctgg gtgtgtcaaa ntcatctgcc aaggccgcct tcacggccct 60 c 61 <210> 147 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 147 taaaagatta tttgaaaaat acttgaagga ngaaagtggc ttcaaagatc cttccagcga 60 c 61 <210> 148 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 148 actatagtta aagccacctg gaaatagaag ngtcatccat tttcatcagt gatttgaaca 60 c 61 <210> 149 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 149 gaagagccag gcccagaaag aagaaaaccc naagaaacac agaagccatc cttacaagca 60 c 61 <210> 150 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 150 ggatgaggac gacctggcct acgcagagac ngagaagaag acgaggacag actccacgtc 60 c 61 <210> 151 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 151 cctggaccac gtgtgggatg aaggctgtgc ngtcgttcac ctgccagagt ccccaaagcc 60 t 61 <210> 152 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 152 ggcaggtcag gctgacctgg ttcttggtca nctcatcccg ggatgggggc agggtgtaca 60 c 61 <210> 153 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 153 ggtcaggctg acctggttct tggtcagctc ntcccgggat gggggcaggg tgtacacctg 60 t61 <210> 154 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 154 aggacgctga ccacacggaa cgtgctgttg nactgctcct cccgcggctt tgtcttggca 60 t61 <210> 155 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 155 aagcaacaca accactactt acccccag ntttagacat tctctcccca actccatggc 60 c 61 <210> 156 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 156 ccagagactt acctcctgga aaagattctg nctgaagacc tccacctaca cagagagcag 60 t61 <210> 157 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g, a or t <400> 157 ggcagccagt gcaggtggca gggttcggag ncgattgtgt gacaagtcaa gatgggtgac 60 c 61 <210> 158 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or ctaaa <400> 158 tagcctgggt gacagagtga gaccttgtct ntaaataaat aaataaataa atagaaaagt 60 a 61 <210> 159 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 159 ttagtttttt tttttctttt gattttagac ntgccataac tactttatattg aagaccttgg 60 a 61 <210> 160 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 160 cacatggcaa ttcctccatc attgcagacc ngatcgcact caagcttgtt ggcccagaag 60 g 61 <210> 161 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 161 tcagatgcca ccggtgccct cgccctcaca ncctccttct ggcaaacctg gtaggcttcc 60 a 61 <210> 162 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 162 tagttttgtt ctttttgtct ctcttcttca ncccatccat gttagctcta aggaggtttg 60 a 61 <210> 163 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 163 tgcgggcctc atgctcgtcg agttcttcgc nccctggtga gtccattctg ccgaggcggg 60 g 61 <210> 164 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 164 gtcaatcttt catcgtcatt gctgaatggc nctctattat gtgaataatc cataattatt 60 t 61 <210> 165 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 165 gcccttggat tgtctcagga tgttgcaggc ncaactttca tggcagcggg cagttcagct 60 c 61 <210> 166 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 166 tgaatgaatc agttttataa ctggggactt ntgtttttaa taatattttg ttattaacaa 60 t61 <210> 167 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 167 ttttaaaaga agtaaaacat ttattaggta ntaagttttt cccatcactg atgtctccta 60 a 61 <210> 168 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 168 ccagaatgtt acctggcaat ttgattcctg ntcccaccat ccttctgcac tagtcacatt 60 g 61 <210> 169 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 169 tagtgatgca atcggccact ctctcccttg nctcctgtgt gtccaacagt gcctaaacca 60 a 61 <210> 170 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 170 cagcatcctc ctgatggtac aggggacagt natagccagc acacccacaa cccagacacc 60 a 61 <210> 171 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 171 ggtgtggaag cggacatagg ggcagccaac ntccagcaca acctcctggc taagccgact 60 g 61 <210> 172 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 172 gcgtacgtgc ccttgctcca caaaggccac ngcagcctga aggtgctgcg ccatgcgcag 60 c 61 <210> 173 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 173 atgcatcatg atttcttgta gcttcttcac nactagagcc tcacacccct gtaacaaaca 60 c 61 <210> 174 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 174 catcctagac atggttcttc gagaggatgg ngaagatgaa aatgaagagg tcagtgctgg 60 c 61 <210> 175 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 175 gcgcaaatct ttttctagtt gcaagatggt ngtctctcct tcttcctgaa taagacaacg 60 t61 <210> 176 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 176 acctcaacag gtttggaagg gtgatgggga ngtcttcggg gtatttcaca cttaggtcct 60 t61 <210> 177 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 177 cattgaagac ttagaaaagg tggagcgcct ntccagtggg ccggagcaga tcaccctcga 60 g 61 <210> 178 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 178 ggggcactcc gagcaggggc cgggccctcc ntgtgtccat taacgacgac ggcaactggc 60 c 61 <210> 179 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 179 agaggcggct gccgccgaca ccatcaccat ngccaccccc gagagcctga cagagcaggt 60 g 61 <210> 180 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 180 cgcgtcgggg tacgtctccc ggatgtattg ntccatctcc aggatggccc ggccgtgcag 60 g 61 <210> 181 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 181 ggtggtcacc gtggtaaggt aggcaatgag ngacctcagc tccttgtcaa actgcagacc 60 a 61 <210> 182 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 182 tgccaattat atctctggga tccagactat nggacatagg gtaattgtat ctgatgtcca 60 a 61 <210> 183 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 183 gcaggtccct ccccgcgcgg aggagatcac natccccgcg gacgtcaccc cggagaaggt 60 g 61 <210> 184 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 184 ggtaactgcg ctcgaccggg tgagagaaga nctcatagag cgccatgagc accgctcgca 60 g 61 <210> 185 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 185 gctgctccgt tggtgacctc cctggctgca ntcccaggct caagcctcat ctttttggtt 60 a 61 <210> 186 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 186 catgctccct gctcttggtc ctgttttcta ngtactgaaa aataaaagaa gggggggaga 60 a 61 <210> 187 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 187 cactcccagg ctgtaacctg tatggggggat nggggtaaga gaggggaggg agctttacct 60 t61 <210> 188 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 188 cacccagccc ttctccagca ccttggcaaa natgtccgtc agcacctctt tgatgggccg 60 c 61 <210> 189 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 189 ggaactatga gcagattgtg aaggcacacc nggacaaccc ccatgaaggg gaggaccagg 60 t 61 <210> 190 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 190 aggtacaatc caaaatcctc gaattggagc nggctgcctg gaaaaacaca gtcatagtta 60 a 61 <210> 191 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 191 gcgcacgatg ctggagttgc tcaaccagct ngacggcttt gaggccacca agaacatcaa 60 g 61 <210> 192 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t, a, c, or g <400> 192 agtcaggctc tgctggtatg cagctgatgt nagggtggtc aggtcactgg agtgaaagga 60 a 61 <210> 193 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 193 caagatcaac aggttaggag agttgatcct nacctctgag agcagccgct atcagttccg 60 g 61 <210> 194 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 194 gattacctcc aatttttcag ccaagagacc ntcagtgccc ccagacctca atctcatctg 60 c 61 <210> 195 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 195 gaagctggag agcaggtgca ggaggctcct ngcgttcaca taattgtcat catccacgtg 60 g 61 <210> 196 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 196 gcgcggctcc tactgggagt gctcacccag natgtgtgcc acggcctcca ccaggtcccg 60 c 61 <210> 197 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 197 gatctgcctg tcgaaacgcc ccggcctaag nagcgcgggg tccaggatat ctggtcgatt 60 g 61 <210> 198 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 198 tctgtattag gtggttgtct ggggtgagtg ngactccact gatgactgta ttgagcacaa 60 c 61 <210> 199 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 199 agtctgtgtg ggatcgatca tgaggcgctc nacaagcaga ttatggagta caaaaggagg 60 a 61 <210> 200 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 200 atcctcgcgg cggtggaagc tgatgaaggc naagccctgt ggaggggcgg gatggggtcg 60 g 61 <210> 201 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 201 gaaggtgtct gagaagtact ggaacagggc nttctgcttg tgcacctcca gccccaggat 60 g 61 <210> 202 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 202 atctttcccc aggtcgtgtt atcgctccca ngaaggcgcg cgtcgtgcag cagcaaaagc 60 t61 <210> 203 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 203 gaagccaccg ccacagcgtg tgaccctcac nctacctgtc ctgaatgcag cacgaactgt 60 c 61 <210> 204 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 204 gtccctctcc acgtctctct ctgggcttga nagctgtggg aaccaatgtg agtcaggacg 60 c 61 <210> 205 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 205 gaagcattac ttgagcagtg cgaggaaggc ngcgggttcc acgtcgggca gctcaatctc 60 c 61 <210> 206 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 206 gtatgtctcg ttgtcggggt ccagctccag ngccttcttg tagtaagcca cggcctccac 60 g 61 <210> 207 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 207 gtgccagaga aagacagccc cgtataagaa ngtcaatgtg cagaacttcc acatcaggta 60 a 61 <210> 208 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 208 ggggcttcac cgagggctac tccggaagcc ncctcttgtg cagaggagcc agtgaggcga 60 a 61 <210> 209 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 209 gcgtccgaag acctgcacag actgcagcgg ncccttggac ggcatggctc cgagcgtgga 60 c 61 <210> 210 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 210 ctctccaagg tcaaagggct cccggggctt nggcttatac tcccgcttag ggcgtgagga 60 a 61 <210> 211 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 211 ggactgcttc tgctccagcc gggctagggc ngcagcggct gccatctgtg cctcattggt 60 g 61 <210> 212 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 212 cagcctgccg ctccgcgtct ccttctgccc nctctcgctt tggcgctggc agctctatgc 60 t 61 <210> 213 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 213 atcgacaagg cgacgggcaa gatctccaag ntgggccgct ccttcacacg cgcccgcgac 60 t 61 <210> 214 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 214 ttgagagcca ggcccaggtc tcacggtggc ntatggacag ctcctcccca taggcctggt 60 c 61 <210> 215 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 215 cctcctgtca gggcctccca gagtgaaggc ngtgaagtcg tcagaacaca tcaacgaggg 60 g 61 <210> 216 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 216 catcgtgtca cagaaacaga tcgcagaccg ngctgcccac gacgagtccc cggggaacaa 60 c 61 <210> 217 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 217 ggcctgggaa atcacgaaga agacctgtgc ntacaccaac cacactgtgc tgcctgaggc 60 c 61 <210> 218 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 218 gcctgttccc ctgtccttcc ctttaggaga ngagtgaaaa acccaaaaag aagaaaaagc 60 a 61 <210> 219 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 219 tctttttctt tccttcccca caccccaggg ntaccaagaa aagaacaaat tcattgctgc 60 a 61 <210> 220 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 220 gcgaaagaac cctggtgtgg gcaacggaga ngacgaggca gctgagttga tgcagcaggt 60 g 61 <210> 221 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 221 tctgtttccc tgataagtgc cggagtacca nggggagccg gatgagattt ccatacagaa 60 a 61 <210> 222 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 222 tcttctaaag agcatagctc aaaaattgta nacacttctt ccgttaattc ctgtggacca 60 g 61 <210> 223 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a, c, t, or g <400> 223 gaaagccaaa ctcgctgagc aggctgagcg ntatgatgat atggctgcag ccatgaaggc 60 a 61 <210> 224 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 224 caatatcact gtcttccacc tccacgtttc nttccactgg aaggttttca gggcagtaac 60 a 61 <210> 225 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 225 aaaaaagccg ttcaatagta ttattgagca nctgtcagtg gtattcccat gttacaacag 60 g 61 <210> 226 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 226 gtggtctccc ggctgggctg ggctgcggag ngtgcacctc acaggaagcg tcgggactga 60 t 61 <210> 227 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 227 cgcccttgca gaaactttat tggggtcagc ntgcagcatc cttccgtact cctcgcagtg 60 c 61 <210> 228 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 228 ctctttaaag accagctggt gtatcctctt ntggctttta cccgacaagg taagagatga 60 a 61 <210> 229 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 229 cattgccctc acgatgtacc ccatgcgtat ngatgagagc attcacctcc agctgcggga 60 g 61 <210> 230 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t, a or c <400> 230 gcgggcagag aggcggacca cggcgaagcc ntgtggcccc tggaaggccc agcagttgcc 60 t 61 <210> 231 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 231 ctttgtaggg agattttgca gctgctgccg ncaacctaca aacctgcctg gcagttttgg 60 g 61 <210> 232 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 232 ccggcttctc ctgcaactct acagactgga ngaggccaca ggtggacagg aggcgggaca 60 g 61 <210> 233 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 233 gtggccagta tcatcagctc cttcttacag ngcacacaca tgctcccagc ccagctgtag 60 c 61 <210> 234 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 234 ctgcgccatg tcgggggcgt tgggcagcac nctggacagg ctgtagttcc ctgcacacac 60 a 61 <210> 235 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 235 ccatgtcctg gtatgttcct ggcatacatg ncacacactg gccgagctca ccaccgaagt 60 g 61 <210> 236 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 236 gctcacgtca aagaaggcct tctcgtccac ngtcttaggg gcacccatag tgggcgtgcc 60 a 61 <210> 237 <211> 61 <212> DNA <213> Homo sapiens <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 237 tgaggatctc agggaactga tctgagtact ntctgagaaa ctccagcatc tcggactgct 60 g 61 <210> 238 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 238 ggattacact cctgagtgat atcgttcagg ntgacatggg catcctgcat ctcctccctc 60 t 61 <210> 239 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 239 cccggcccac cggccctccc gcctcccgtc nggcctctaa aagtcacagc tcagttaaga 60 g 61 <210> 240 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 240 atatcgaaga ctggtatgga gaaaggcacc ngggaccact ttttggcctg gatcttccct 60 c 61 <210> 241 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 241 tacaccagca tagtggaaag tgttcagggt natctgagtg gcaggttctc caagagactg 60 a 61 <210> 242 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 242 tggagaagcc gaactatata gtgcctgact ncatgccagt tgtgtatgat aaactgccgc 60 a 61 <210> 243 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 243 cgtgggaaca gcagagggtg gttaatgatg nctgtcacca cgaccagaca gacccggaag 60 a 61 <210> 244 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 244 ctggcagatt atggtggata tgaaggaggc natgtacaag actatgaaga cttcatgtga 60 c 61 <210> 245 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 245 agctgcagga ccaagacagc atcctcttca nctccacact gcacggcggc tgaggcctcc 60 c 61 <210> 246 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 246 cggtcacgct ctcggtcacg gtcgcggtcc ngatcccggt gtctctctcg ttctctgctt 60 c 61 <210> 247 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 247 ttctaagcgg cctggatttt cttcatgcaa nctgcattgt tcaccgggac ctgaagccag 60 a 61 <210> 248 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 248 actgcctcca gtgtcttcaa tcttgccttt ntccacgtcc atcctgcagg tggacatagc 60 a 61 <210> 249 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 249 accaccatcc actacaagta catgtgtaat ngctcctgca tggggggcat gaaccgccga 60 c 61 <210> 250 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 250 agtacatgtg taatagctcc tgcatggggg ncatgaaccg ccgacctatc cttaccatca 60 t 61 <210> 251 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 251 gactctcatc gttttcttga aaggaacttg ncgcaaaagg cagcagagag gtctcggtac 60 g 61 <210> 252 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 252 gaaggccaac aacaaccaga agcccaagac nagcaaggaa catatacata aaaattctgg 60 c 61 <210> 253 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 253 cgcatctgcc ctcaggaata tacctgctgc nccacagaaa tggaagacaa gctgagtcaa 60 c 61 <210> 254 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 254 aagcgcgacg ccagttctcg ggtgccggcc ngcggggacg cgcggcccgg ggttcgggac 60 g 61 <210> 255 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 255 tttactacct ggtgaccttc tgggaggagg ntcggattca atctgaactt aaactttcaa 60 c 61 <210> 256 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 256 ggttctggag ggcacgcagc tttgaggatg natcagggcc agctgtgatc acctcatgaa 60 a 61 <210> 257 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 257 gttacctcca gcgtttggat gtgctcaaac ntgtctgcat cccactgctt gatcttgtgg 60 t 61 <210> 258 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 258 gtttccactt ttcctgatta tcatgggaaa ncgatcatct aatgaagtgt taaatgtgat 60 a 61 <210> 259 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 259 atcatcagct gtgtcacaca cctcatattg nctcgagtgt gattgattca gatgaaaagt 60 g 61 <210> 260 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 260 cttcctactt agcctctacg cccaccgcta ncgggctgac tttgcggaca tcagcatcct 60 t 61 <210> 261 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 261 ggtaaggtta tctgatttaa tggaagaaac ntgaagctgt atgagggcca ggcggaaagc 60 t 61 <210> 262 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 262 gcaattcact gtaaagctgg aaagggacgg nctggtgtaa tgatttgtgc atatttattg 60 c 61 <210> 263 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 263 gcgccaggtc tcctgcgtcc agacagtcgg ncaggctcgg ctgggcgttg cccacacgat 60 a 61 <210> 264 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 264 agcaagatct ggacgatgaa gaaaaaactg ncaagttcat tgaggagcag gtgagaagag 60 g 61 <210> 265 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 265 ccttctgctt ctctgtccag gcggacagct nctcaaatcg ccctttcata gcttgattat 60 t 61 <210> 266 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 266 caagccaaga atcacagtcg ggaactgtat ntgatgctga gttgtcctgc tcaggcattt 60 c 61 <210> 267 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 267 ccctgattgt tgtccacaca gtatgtactc nggatgtctt ccaactgccg gctcagctcc 60 t 61 <210> 268 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 268 tcggagctgg cggctccagt agctgctcga ngtccaagtc ttgggcacgt ggcccagtcc 60 g 61 <210> 269 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 269 ggggccacca acttcctgtt ccagttgagc nctgggctgc agctggaagc cgtggtgtcc 60 a 61 <210> 270 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 270 cgggacaaaa tgaactcccc ggggctccag ngcaaggagc ctggcagcag cttgcacctg 60 g 61 <210> 271 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 271 gctcagtgag ctcatcctgt tggctgcact naggtgcagg gggtggctct gccctgggga 60 g 61 <210> 272 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 272 cctgtggggg tttctgttga cttttcacaa ngtcagcacc gcacaggtga ttgagccgcc 60 c 61 <210> 273 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 273 cactggtaag gcttctcccc aagatggatt ntctgatgtc tgatgaggtg tgaacttctc 60 t 61 <210> 274 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 274 agtaccagaa gcattgcaga actggtgagt nacgttgtag agtctgcagc aggacgactg 60 t 61 <210> 275 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 275 acttacccca tccaggaacg aattcttgct nttggtgaat actctcttgc tttacctcca 60 a 61 <210> 276 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 276 gcagcttgat gaatgtgctt ctgctattac naaggcccaa gtagcaatca agactgctga 60 c 61 <210> 277 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 277 ccgccaacct cgaagcctta cctctttggg ntctccagat ccagtgagca tctttcgttc 60 g 61 <210> 278 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 278 gtcacagaag ggctgtccaa ctcaatcaca ntccggagtc tccctaactc cctgccagaa 60 a 61 <210> 279 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 279 acctccgttc tctctcctct cttccagtac nctcctcccc tcaataagct attctgccag 60 c 61 <210> 280 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 280 cctcccctca ataagctatt ctgccagctg ncgaagacgt gccctgtgca gttgtgggtc 60 a 61 <210> 281 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 281 tctgaatggc ctctatgctt tccacatcac ncttcaaggc caacgcctgg atgaggcggg 60 t 61 <210> 282 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 282 agcgatgacg acgacgatga tgacgatgac nacaccgagc agagtgaaga ggggccggag 60 t 61 <210> 283 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 283 ggaactcctt caggtagctg cggtgtttgc ncttggccca gatagtcatc tgggtgaagc 60 c 61 <210> 284 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 284 ctaagctctg tggggctcaa atctccatag nccccactga aaatggggat agcgatgacg 60 a 61 <210> 285 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 285 ttctgtccag gccatctaaa attttcatgt natctgaagc caattggaaa tcaaagacct 60 g 61 <210> 286 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 286 tacacaacat cgatcaggac ttttttgatg ncttgccatg tgagtaccca gccattgccg 60 c 61 <210> 287 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 287 gtcaatgatt tgtagagaag gccgttcagg nccctcaggc ggatgctgtc ttccttccta 60 g 61 <210> 288 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 288 aaaaatgcat cgaggaaata tacacagctg naaaaatttt gtgatggtct catttttggt 60 a 61 <210> 289 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 289 tgagcgaggc ggccaagagc tccggggccg ncggctctct gccctccacg ccgccgccgc 60 c 61 <210> 290 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 290 gagatctcct cgctccggcc ctgcttgctg ncctttgggg cagagggctc ctctatccgg 60 g 61 <210> 291 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 291 tctactggaa cctgttttcc caatagcatg ncatcggctc tgtgaggggc cggatttctc 60 a 61 <210> 292 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 292 gaaaaaccgt tcttataagt tgttggaaga nagcgagagc ggcgaggagg cagtgggtag 60 t 61 <210> 293 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 293 gtgagcacaa cttgagcaag ccagaattta ntccaacatc tatcaaattc aaaatccagt 60 t 61 <210> 294 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 294 ggcaggagta aggcctgaac tcacacagct nctcgtgctc tgcctttttg gtgtgtggca 60 g 61 <210> 295 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 295 gcgtcaggag gttgtagatg taaagaccat natgaacaca tggacactgc agaagggctt 60 t 61 <210> 296 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 296 gaacgcgacc ctgatgagtt aagatttaat ncaattgctc tctcagcggc atagcatctt 60 g 61 <210> 297 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 297 acagctgcct atgtcaatgc tatcgagaaa ntcttcaagg tgtacaatga agctggtgtg 60 a 61 <210> 298 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 298 tccttagtga acaacagaac gcaagccaag ntagcagagg aactgggcat gcaggagtat 60 g 61 <210> 299 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 299 ggctccttgg ccttgatgat ttggctgatg ncaacacctc acagccatga gaccgagcaa 60 a 61 <210> 300 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 300 tccatcctgt ttcagaacct tcattgacag ntcgagaatc agtctgagga aatcccatgt 60 g 61 <210> 301 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 301 aggagtattc ttgtccatcc catggaaaag nttgctgagc ctggttaaca aacaaccaaa 60 g 61 <210> 302 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 302 agcgatccac ataaggcatt gcgaagaacc ncctcctgtt gtatctttta tttaggtacc 60 a 61 <210> 303 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 303 ccctcaagtt cctgtgcaga gatctgtggg ncgccatgtt ccgaagcac atggacggac 60 t 61 <210> 304 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 304 gcccatcata gcgtatctca tctcaaaggg ncaggtatgt gttgtcatgc accttatatt 60 c 61 <210> 305 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 305 agtggtggac agggttatgg aaaccagggc ngtggctatg gcggggagtgg cagctatgac 60 a 61 <210> 306 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 306 accccttctt actatacaac ttcagatgcc ntcatttcta cagagactgt attcatcgtg 60 g 61 <210> 307 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 307 atggctttga agatgttgcg actgagttag ngaagagtaa acatgctctt atttgggctc 60 a 61 <210> 308 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 308 catactgatg aggcaagctc tgaagtcctg naccccaact atcagagctg ctgggtcctg 60 a 61 <210> 309 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 309 agcaaagcag attatgagct gtacaacaaa ncatctaatc ctgataaggt ggttgggaca 60 c 61 <210> 310 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 310 gctgctctcc aggggtccca gagcctctac ntgagccaca gcagtaacac ccgtaggttc 60 a 61 <210> 311 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 311 ttactggtca atgaagtcca cacccacacc naaagcttct gccatatagc cgagggttaa 60 t 61 <210> 312 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 312 gaaaccgtca ttgtcgggct tcggggcgac nctaggcttg ccactgagca tgttaaaggc 60 g 61 <210> 313 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 313 agataaagaa agacatacat ttcttgcaaa ncacatcctt cttcagcagg aggatcccaa 60 a 61 <210> 314 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 314 gaaaaaattg catacaaaaa agaagactgt ngatgggaac ggtggagaaa gcctacatat 60 t 61 <210> 315 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 315 tctgattttc agggaaaaca tgagaatcac ncagttatactc ctcgatttcc aaaattaaaa 60 g 61 <210> 316 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 316 actgactaag cctttaactta ccagatgggt ntgggaacac ctgatcaatg gtaagctggc 60 c 61 <210> 317 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 317 ttcaagacaa taactgggac tacaccagat ntgctcaggc cttcactctt ctcaaggtaa 60 a 61 <210> 318 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 318 tagttttcat tgcacatttt tccttacaag ncgggccttg tccttcacct tttgcatctc 60 c 61 <210> 319 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 319 agggggagac tgtgaggttt gttgaccatc ngtttgtacc tggggctgtg ttccagcttc 60 a 61 <210> 320 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 320 catacctgcg gaacctcggg cggtaagtcg nattccgatg agcctggagc tgtgttccct 60 c 61 <210> 321 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 321 aagcctagtt ccatctgctg cagtctgcag ngtttccttt ggaatctcca taattgcttt 60 g 61 <210> 322 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 322 tggtcctgtg cactacagtc cagaggaagg natccactgt gcagctgaaa caggaggcca 60 c 61 <210> 323 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 323 cagctcggtg tccccctggc gcgtacattc nttcagttca agaaggctct gagccacttc 60 c 61 <210> 324 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 324 cttgctagga gaacgcgttg tggcctttgc ngccgtagaa ggaatcttct tttccggttc 60 t 61 <210> 325 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 325 gtgtgagact tgtggggacag aagaagcgaa ntacagatgt ccacgctgca tgcgcttttc 60 c 61 <210> 326 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 326 catcagcaag acattagtgt tatgacgatt nctgagcatc ctgacatcca tgatttagag 60 a 61 <210> 327 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 327 atttaattct tcatcttggg aaacaatttg nttgctattc atcattatct tattaaattc 60 a 61 <210> 328 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 328 cacacccttt atgagcttgg tgtcttccag ncgcccacct actttgcctt ccactttaat 60 g 61 <210> 329 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 329 gggtgctcct cactggatca gtgccacacc ngggcagccc tctccaccag tctcctctat 60 g 61 <210> 330 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 330 cctcctgctg ctccaggcct acaactccca natggtctct agacgctccc actgcctctt 60 g 61 <210> 331 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 331 tttttctaaa aattctttac agtacaccag nagattcttc ccggtcaaat ctttttgaag 60 a 61 <210> 332 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 332 tgaggtaagg gctccctgca tctcctagca ngtggggacag cactatctgg aaggcctcag 60 c 61 <210> 333 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 333 gcaagcatct ccgctttctt cttcagaaac ncaacaatgt actctgcaag cccttccttc 60 g 61 <210> 334 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 334 agcctctcgc agggccccgg gccggccgcg ncttgggctt ccgcctccgg ctccgggctg 60 a 61 <210> 335 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or a <400> 335 tgctcttagg cctggctcct ccccagcatc ntatccgggt ggaaggaaat ttgtatcccg 60 a 61 <210> 336 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 336 cccgagtatc tggaagacag gcagactttt ngccacagcg tggtggtacc ttatgagcca 60 c 61 <210> 337 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 337 tcctttttcc ctttagcaga gtcaggggat nttggggacag tcatctgtcc atcagatgac 60 c 61 <210> 338 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 338 catcttcttc ttcatcgagc tctgattctt ncagcagttc ttcagattcc gaagatgagg 60 t 61 <210> 339 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 339 agcgtcaagt ttgagatccc ctatttcact ncctctggca tccaggtatg aatgtgttag 60 g 61 <210> 340 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 340 gcttttgttt tcttgttgca gactctggtc nttttggtat tcctttaacg atattgttag 60 a 61 <210> 341 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 341 atcttgttaa agtttggttc cagtgtcaga ngcaagcaca gttattgctg tgtcttcagc 60 t 61 <210> 342 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 342 ggtcgcaggc ggccatcatg ttcttggcat ngaagacctg ctgggtaagt tcaggcacag 60 t 61 <210> 343 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 343 cacgcactct tcatcaaatt tttgagaaac ntactgataa tggcactgag ttttcagtta 60 a 61 <210> 344 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 344 aggcaatggg tcgtgcgaga tgaacagtgg ncagaagaat gaggagaaga gtctggaaca 60 c 61 <210> 345 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 345 cctcttaacc cacagtgaac ttaggaggac ntctactaca ggcactgctg gaatactggc 60 c 61 <210> 346 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 346 gccattgtag atgccgccct cagtgccttg ngccagctcg tcaaggatcg ccttggtggg 60 c 61 <210> 347 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 347 gtgaagaaca cgttgccttt ttcaagcagg nttttggaga acaagctcta atgaggccta 60 c 61 <210> 348 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 348 gtcgagatta tgagtacaac agatacagag nctattacag acaatacaac cgggatgtga 60 g 61 <210> 349 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 349 gggatcaggc acgcgtcgcg gcccggcctg nggaccaggtc gtccctgcag cagcgcctga 60 t 61 <210> 350 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 350 gttttcttcc agattgaaag cttacgcaca ntcacagact ggggtccaaa ttttaatgag 60 g 61 <210> 351 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 351 gttggggttc tcaatgtcaa tgagcccctc nacgcctttt cgcttttgct aggacagaac 60 a 61 <210> 352 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 352 aggtccagaa gcagctggca aggatgacac ngtgccccga gcaggagctt cgcctgcagc 60 g 61 <210> 353 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 353 ggctgtcaaa tactcataca gtgctttagc ngaggccaca tctttgtcta aggctgaagg 60 a 61 <210> 354 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 354 cacaaggaac ggaagaaggc caatgaagtg naccgcatgg tacttgtggg agatgtgaag 60 g 61 <210> 355 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 355 gccatcttca acaggaagat cagcaggaac nccaccttta aggtgctgaa ggacagagta 60 a 61 <210> 356 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 356 aggaatataa agagaaggag atcacaatca ncaaccctgc acagttccct gagaagtccc 60 a 61 <210> 357 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 357 gatgcaggag atgatgatga taaggagggc nccattggtg tgaggaacaa ggtggctggg 60 g 61 <210> 358 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 358 acttctgaag gtttggccac atctttttca nccacatatt ttgcccatgg tcccaagaaa 60 c 61 <210> 359 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 359 actcacatct tgattgtatt ccaagaagac ntggaaattt aaatcttttc tcaaaatagg 60 a 61 <210> 360 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 360 tgttagggca ggccaacttc tttatgatgt ngcattatgt gctggttctt ttccgagggt 60 c 61 <210> 361 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 361 tcttcaagat ttagattcaa cccctcttct ncaaacacct ataaaagcag tgtgctatta 60 g 61 <210> 362 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 362 cttccttctc ctcctcttct tctttctctt natcctcctc cgaagtcact tcctcctcct 60 t 61 <210> 363 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 363 actacatgag ggaaggggca ccgctgtgtg nacacgaact tctgcagctg ggacagcagt 60 t 61 <210> 364 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 364 atcaggtaac acctggatcc cctttttctg ntgattattg ttttgtgttg ttgaactttt 60 a 61 <210> 365 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 365 agcaactccg aaaagtagtt ctgagcatgc ncatttgccg aaacctgtgg aagcctttaa 60 g 61 <210> 366 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 366 tcttcttttt ggctgaagtt ctttgtttct nctgcttttt attatcttct gagcttccct 60 c 61 <210> 367 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 367 ttcgtgatac aaggaatatt attgtggaga ncatgctgaa taaacaaaga gcctaggtca 60 a 61 <210> 368 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 368 ggagcccctg atccgcaggt cagatgacaa ngagaaagcc ttgaagaccc gcctggaggc 60 c 61 <210> 369 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 369 tgagcaatga cgacgctgta cgggtgcttc nggagatcgt gtcccagaca gggtgaggtg 60 g 61 <210> 370 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 370 atgatgaatg tgggctggcc tatgttaaac nacaaggaat tcgtttccaa gaaaagccct 60 a 61 <210> 371 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 371 gtatcgtcaa ggcgctcttg cctacgccac nagctccaac caccacaagt ttatactcag 60 t 61 <210> 372 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 372 tgctaaagcc tttgctcttc ttgatctcct ngcaggcagt actgacagcc atgatgtcag 60 g 61 <210> 373 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 373 ttaaatgcag accatggatt cctgtgattt ncgaggactg acttctagac gaaggacctc 60 a 61 <210> 374 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 374 aaatgaactg gcttgtgcag gccatctacc ngaaaattta cgccacgaca gtcggacatt 60 t 61 <210> 375 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 375 tataaaagcc ttccgaatat tggcaagaaa ngctgaaaaa ttgttggtct tcctgacttt 60 c 61 <210> 376 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 376 tccttgctcc cgagagttta tcaaggcaca nggcccagcc ggagaggtgt actgccccag 60 t 61 <210> 377 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 377 taggaatttt ctttaggctt ccacttccac ngctgctgag actacgcaga cttgcgcgat 60 g 61 <210> 378 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 378 caggagtggt ttgtcggagc agcgcttgcc ncaatgattc cgtgttttta caggtataca 60 a 61 <210> 379 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 379 tccagtagga agtggaagcc atcattggtt nggtatttct gaataccgcc acagatacca 60 g 61 <210> 380 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 380 cttgatcctc tcctttccca ggcctagcca ncatgaccca gcacctggag cctattctga 60 a 61 <210> 381 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 381 ctgtgtggca aagagactgt ggtgaccagc nccacggagc ccagtcgctg tgagtacctc 60 a 61 <210> 382 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 382 gtgatataga atctctaaaa gctagtaatg nagactcatt cccttggaat aatatgcgac 60 t 61 <210> 383 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 383 tgcactggca ttgtaccagg tacttactct nggtaaagca gcgacttggt aagcagccct 60 g 61 <210> 384 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 384 tggcccatct tcaggatcca tcaccagaaa ncccgctata tcttcgacct cttttacaag 60 a 61 <210> 385 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 385 gtccagttgt actcacctgt cttgtctttg ntgaggtctc aatgaacgga atcccgtaac 60 t 61 <210> 386 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 386 gaatttcctg atttctcaag aggcttaaaa ntacctccat atttggcagg tagggaaagc 60 t 61 <210> 387 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 387 cagcacaact acgccgcacc cccctccaca nggaaggact atccagctgc caagagggcc 60 a 61 <210> 388 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 388 cagaggcgga gctcaggaag gtggatgagg ncatcgccct gttccagaag atgctgtgac 60 c 61 <210> 389 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 389 agccaactct cggaggtggc cagtaaattt ncaaaagcga ccggcgctgt gagtccttgg 60 t 61 <210> 390 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 390 cgaatcacag agctaaagga ggaaatagaa ntgaagaagg tactggatac gtacgtctgc 60 t 61 <210> 391 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 391 ccattactgc ctgtgctggg ccacccgcgg nggccaggag cttggtaaga gatccatcgc 60 g 61 <210> 392 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 392 taccccagtc tattccagga gtctcagcaa ngatgccaga gtcggaaaca gcttccaccc 60 c 61 <210> 393 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 393 acagagctta cctcgtaacg ctccccaaac nctgttggcc ttgaggacgg ctactggttc 60 t 61 <210> 394 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 394 tctctcaccg tttggtccca gtgacgtccg nattgtgttt gctacagctt tggcagccat 60 g 61 <210> 395 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 395 gcaacccaag cccagagtct gagggcagca nggtgcccac acagcctgag gaaacagaag 60 a 61 <210> 396 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 396 agggttggct tcaggcccat tgggagcacg natgtacttg gggaagagat ggggaatgac 60 c 61 <210> 397 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 397 ccactgtggg gaagttgaac tttcgaagca ncatacaaag gatctggcag gtcctggtgg 60 g 61 <210> 398 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 398 aagagcttca gtctcatgat cagaacacca ngggctgtgt acgctaacag ctgcagagcg 60 t 61 <210> 399 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 399 gggacggcgt gattgaggcc agcatcaatc ncgagaaggg atacgtccaa tccaaagaga 60 t 61 <210> 400 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 400 atgaacgtaa ggaagagaag tcgttacacc ngagtatgcc tattattaca gaggaggagg 60 a 61 <210> 401 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 401 cagaaacttt attgttacgg gcttacagga natagataaa tgcagacagc agctgcacga 60 t 61 <210> 402 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 402 atcgtctcaa agatcttccg tttattgttt nacataggtt gtctaatacc ttgagcttag 60 a 61 <210> 403 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 403 ctctcaagtc gaccacgagt ccctgcatcc nggggcccta ggctcagctc ttctaagtct 60 g 61 <210> 404 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 404 attgttcctc caatgattcg gcccaaaggg naccaagccc ggtcatcaaa ccagttatgg 60 a 61 <210> 405 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 405 tagtcggatt tctgtggcct cacacacctg ntaaagctgg acctcagcaa gaacaagctg 60 c 61 <210> 406 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or c <400> 406 ccaagaaaaa ttaaagaaga tgatgctcca ngaacaatag cttgccctca taaagtaagt 60 a 61 <210> 407 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 407 ctctatgtca atatctccag ccgtagtttt nagtaaaacc tatagaaaga tcatgacatc 60 a 61 <210> 408 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or g <400> 408 taaaagcacc tcgcagaatg aatgcctccc ngaagcaatg tcttgcagaa ttttaggaga 60 g 61 <210> 409 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 409 agcagcagct atgggcaacc ccagagtgga ngttatggtc aacagtctgg ctatggtgga 60 c 61 <210> 410 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 410 cgcctaggac tttttcctag ggccatggcg nactcgacgt ttttggcacc agaactaagc 60 g 61 <210> 411 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 411 ggcggctgtg cagccaacat ggcggcggcg ncggcggcgg gcccggagat ggtccgcggg 60 c 61 <210> 412 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 412 tccgtatgag gaatgttcat aaccacctct ncctccgcct cggcctcctg cttgctgctg 60 g 61 <210> 413 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 413 ccacaccgta gtggtagcca gaggccacat ncccacagac caggcagagg cgtttgggta 60 g 61 <210> 414 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 414 agcagctggg cccgccgcct cctctgcctg ntcggcctct tggtgctgct cctgtggttc 60 g 61 <210> 415 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 415 tctttctgat gtacacaata tgaatgtctt nacttcggta ttcttcatca tgtttgtcca 60 a 61 <210> 416 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 416 tggccatgag ctgcgcaggg ttgatggaat ngatgtctcg cagagaagcg tgtgagctct 60 g 61 <210> 417 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 417 tcaaataaag gtgagctttc tttcatggca ntatcaatct aattaata cagacaacac 60 a 61 <210> 418 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 418 aaggggaaga cgtcgaaggc gactgcaaca ngttggctct tcacatatca accagccctg 60 g 61 <210> 419 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or t <400> 419 gcctctgcat ctgcccaaca acaacaactc nacagagtgg gaaaaggtga agctcctgtt 60 t 61 <210> 420 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 420 ccgtgtgtct cccgcagccc ggcgaccatg nccaggaaga agggggcggc ctgggaggag 60 c 61 <210> 421 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 421 gagtcccagg cacgggtcag ccagctgaac ntgcagatgg aggggcagca gcggcgtctg 60 g 61 <210> 422 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 422 aaccttctgg gacggggacag ctttgaggtt ngtgtttgtg cctgccctgg gagagaccgc 60 c 61 <210> 423 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or a <400> 423 ccaggaattc tttgtctaac tgtggaattc nacaacccaa atatggagac agaaaagttc 60 a 61 <210> 424 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 424 atcgcatgat tgactttcta cggttccggc nagaaaagga aaaggcacca gaaccgtttg 60 a 61 <210> 425 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is a or g <400> 425 ctaagacaag tacctggccg gaggtgctag ntcaggaatg cgtgcgtcaa cgactggcac 60 t 61 <210> 426 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 426 gccacacaac caacctcact ggggcagcta nctggtcagc ctccaggcca gtccaaccag 60 a 61 <210> 427 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 427 ctacaggccc ggaggaacca tggtgaccta ngggggaatg gccaaacagc ctgtaacagc 60 c 61 <210> 428 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is t or c <400> 428 tgactcctct gatggcagct tatttaaaac ncagtgtgct ccttcaccta tacaaaagca 60 a 61 <210> 429 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 429 ccgccctgga aggttctccc tctctggacg naggccctcc tccctttggg ctggagtggc 60 g 61 <210> 430 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is c or t <400> 430 tcatacctgt ttgagcatca ctggatgtgc ncttgtcctt aggaaatgga ttatctagga 60 a 61 <210> 431 <211> 61 <212> DNA <213> House mouse <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 431 ttggaaacaa tgctggctct gaagaacaat nacctgcgta aaatccctgg ttataatcct 60 g 61 <210> 432 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is c or g <400> 432 ccgagaagat gccgaaggcc aagtccgcag ngagtagccg ccggcgggat cgtcaggagc 60 a 61 <210> 433 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is g or c <400> 433 gcgacgctgg ggttgtgttc acctccggcg nctccggctc gctgcggctt ctctggcttc 60 t 61 <210> 434 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 434 gatcttagct ctccatcaag atcctgctgc ngcagtttcc tgaaatctgc atcaagggcc 60 t 61 <210> 435 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is c or a <400> 435 aactgagtcg ctatccagag gacaagatta ntcctgagaa cttgccccaa attcttctac 60 a 61 <210> 436 <211> 61 <212> DNA <213> Mus musculus <220> <221> misc_feature <222> (31)..(31) <223> n is g or t <400> 436 gtacctgtaa gcctggagag taagaaggct ncccgggcgg ctaggtttgg aatttcttca 60 g 61 <210> 437 <211> 150 <212> DNA <213> Mus musculus <400> 437 ccctggagct gcacaccgag ctgttggaga gcggccgcga gctaccacga ctgcgcgatt 60 acttctccaa tcctggcaac ttcgagaggc agagtgggac ccccccaggg atgggggcgc 120 ccgggatccc tggcgcctcc atcgtcggag 150 <210> 438 <211> 141 <212> DNA <213> Mus musculus <400> 438 ctggaccggt acctggctgt ctgtcaccct cttcgaagcc tccagcagcc cagccagtcc 60 acctaccctc ttattgctgc tccctggctg ctggctgcca tcctcagcct ccctcaagtg 120 ttcatttttt cgttgcgaga g 141 <210> 439 <211> 157 <212> DNA <213> Mus musculus <400> 439 ctttaaaaaa ttacagtaat aataaattag ctattgctct tcagaggctc acggaacagc 60 taacacaaca ggaccaggtc cagagttagg tccgtatctc aggttctcga gctgcccggc 120 cctctttaaa gcttagacga atttccaaat acaagac 157 <210> 440 <211> 191 <212> DNA <213> Mus musculus <400> 440 gctaaagtct cttgaatatc tataaacagg aaatcatatg ccaattacta gttctgaaga 60 gtgtctacat cattaaaaaa acctttcatt tttctttctt cctttttttt tttttggcga 120 tacagatttc aagagtaacg ctggaaaact gtgaaaaatg ttatttaaaa aaatatatgc 180 atatgttact g 191 <210> 441 <211> 141 <212> DNA <213> Mus musculus <400> 441 ggaagaatta aatgttcttg acattccatc taatagacag tgggtggcat catcttaagc 60 agcacatgat ggaggtttga atttggcagt attttcgtta tttgggctac aaactctacc 120 caaatttgaa ggactttcta c 141 <210> 442 <211> 193 <212> DNA <213> Mus musculus <400> 442 tggttcccct ccaactacgt tttggaggaa gcggacgaag ctgcggctga ggcccccagc 60 ttcctgagcc tacgtcgggg cactgcactg agcaatgggc agggtgcacg ggtgctgcac 120 gtggtgcaga cgctgtaccc cttcagctcg gtcactgagg aggagcttag tttcgagaag 180 ggggagacca tgg 193 <210> 443 <211> 179 <212> DNA <213> Mus musculus <400> 443 gtattttctt tatgttaaag ctgtaattca aagttctcat ttttaaaaat gattttgtat 60 gcttagattt ttccagtgtt tcctattatc ctttttatat tttatataga aatattataa 120 cccaaatgac cattttttcc attatcattc tacatattaa aaaaataaaa ttattttta 179 <210> 444 <211> 180 <212> DNA <213> Mus musculus <400> 444 ctttgcccaa tccccacttt tttttctcct tctaaaagag acaaagggaa atacttaaga 60 accaatagtg acagcgacag caatcattga gttgcagggt acctttgtct ctggggggca 120 cgcagtaatt tttacatgtc tgccactgag tgtcaagcct tttcttttct tcttctttcc 180 <210> 445 <211> 177 <212> DNA <213> Mus musculus <400> 445 tagtgagata gcacctatta attctacact agaaactgac ctttaccgcc taattttcaa 60 gttaaatgtg atggtacctt gtgtgaagac ggttggggca cttaccatgc cggccggcct 120 tctattgctt cttttgctgg gctccctaca aagcatcggt ttccattaag tcaaaat 177 <210> 446 <211> 215 <212> DNA <213> Mus musculus <400> 446 atttataaag caataaatat ttgaagcaca aacaaactgc acttgtgtaa acaaactgta 60 caatgactga tgagagatgg ggagggggct cagaggattc caagaagcac aatacggtca 120 tcctgaatat aaggtaggct aagagagaga catctcagaa gcacttgcgg tggacaatgg 180 atgggcctgc ctcatcatac tcttgcttgc tgatc 215 <210> 447 <211> 194 <212> DNA <213> Mus musculus <400> 447 ttcagctgca gagacagagg gcttcatagt caagctctga agaaaggatc aaatatgggg 60 aagtaggtct atctaccaat gaagcaaaag caacaggcat atgctgtgtc agataacaca 120 cacacacaca cacacacaca cacacacaca cacacttacc agtggtgaca aaggagtacc 180 cgcgctcagt gagg 194 <210> 448 <211> 178 <212> DNA <213> Mus musculus <400> 448 cctgcaaaag ctattgttac aattcttatg gagttccccc atgcctctta taaatgagcc 60 atatttagtt ttaaacaaat ttcttgaagt aaacagtata tatgcctgat tttcatctct 120 cttggtgagc ttccaaaaaa cttggaagtg aattagtgtg caatttgcat ccaaatct 178 <210> 449 <211> 197 <212> DNA <213> Mus musculus <400> 449 attaacacag ctctgcagct actagaaatg aatttcaaag atggtaaatg aacaaaagcg 60 attcatatct ctaagaaaag caaacactgt gcccagaacc atatacactt tgaaaaggta 120 cagtatataa aacctcttta actctcccac ttaaagaaac agcggaaggg aacgtttgga 180 gaaaggaaaa ctgactc 197 <210> 450 <211> 207 <212> DNA <213> Mus musculus <400> 450 gctcgaatga tcaattccca ttttatgatc gctgacaaag tcaggctaga ggcggggtga 60 gaccgcgttg ttggcttggc cgggacaggg gcttcgggta cgcccagctc cgcccggcgc 120 ctccggaggc tgctctctct ccagcgagtt cagagacctt ggcaaacttc cctcccccac 180 acgcagccga gacttctgag ttgtcac 207 <210> 451 <211> 137 <212> DNA <213> Mus musculus <400> 451 ttatttttgg cgtgggaacg cggggagcac ggcggtgaga aaggccgagg ctgccagcgc 60 cgctgacggg cctcttcctg tattttacac cttttgcgaa ttccgctcct ttggaaaggg 120 aataatggct ttgggat 137 <210> 452 <211> 155 <212> DNA <213> Mus musculus <400> 452 ctttccatcc tggaccttga cccaaggggg tctgggaatc tgctagtgtt ttggcacaaa 60 acacactgtt tttcctcttg ctatcattta gatctctaga ccttgtgcag gacactgttt 120 atgctactta actaggctct gtgggagtga cgaca 155 <210> 453 <211> 115 <212> DNA <213> Mus musculus <400> 453 tttaaccatt ggaacattat ttcataacta gtttttaaaa tttattttgt catccagcca 60 ggtttctttt ttttttttct ttttacattg tattaatacc aaagtgaaaa acggc 115 <210> 454 <211> 174 <212> DNA <213> Mus musculus <400> 454 gtaaatattg acattttaat tttgtttagc ataccaagct ggggtttccc gttgcttatc 60 ttgctgtaaa aactcctcac ctcccctcgc actgccctgc agactgtcgg gaaaagatct 120 gaacagagca gccccgggtg ctctgccctc tttgctaaca aggcttagtt ttgt 174 <210> 455 <211> 193 <212> DNA <213> Mus musculus <400> 455 tatcctgctc gagggcctgg gaacgtggca gggacctggg cctccgttct aattaatagt 60 cttttttgtc cttttttttt ttttttctgt tttttttttc ttacccctac tggcaaaaaa 120 ataggagggg gggggtgcta ccggtaattg ttttcctcaa aggctgcagg gagttatcag 180 ggtaataaag tta 193 <210> 456 <211> 162 <212> DNA <213> Mus musculus <400> 456 agtgtgcact ccgcaaaact ccaccagtgc cctttccttt catgatctca acaagcgcta 60 ttacaacacc ttccattgca acttcactat ttcctgccag tcaataagtc agcatgtgga 120 tatggctctg gtccgtctta tccatcaatt cagtacaatg at 162 <210> 457 <211> 197 <212> DNA <213> Mus musculus <400> 457 caattgaagg tccatcgcat tattcatcaa atagtgaagg atcgtgttca gtgttcagct 60 ctcccaaaac cacaggcggc ttttcaccaa gtgttccttt ccagtcagaa gatggccgaa 120 gggacgacag tctgtcttct accagtgaag actctgagaa ggatgaaaag gatgaagacc 180 gtgagaggga aagattc 197 <210> 458 <211> 201 <212> DNA <213> Mus musculus <400> 458 ctgtttcctg tgaaaaatac atagaacaat aatagccttt gtttctaatg ttccaactac 60 taaaacagct gaacaaataa catccatgct ttcatttttt catgctttca tttgtaataa 120 tttattccat gtacacgttt atacagaatc atttggctta ttggatgttt catcgtttaa 180 aaatcaaaat ttagaatttt a 201 <210> 459 <211> 139 <212> DNA <213> Mus musculus <400> 459 attggcagag catttgggta attcttccca tctccaagtg gctgccttgc acattgtcat 60 gaatattact tagagccagt gacactggct acaggctgac tcttcccaac atgtggactc 120 aatttgctct gctctatcc 139 <210> 460 <211> 150 <212> DNA <213> Mus musculus <400> 460 tccctctgct gtggttggct ggctccaggc aagatttggg tagaccagta tggaagaatg 60 catgcagccc gtggtgtctg tgtctagaac ctggctgcca ggatttttgc aagcagatac 120 tgcagcttgc ttgcaaccgg gcccaggctt 150 <210> 461 <211> 203 <212> DNA <213> Mus musculus <400> 461 ttacgaggtt ggcggctcta agaggcgcgg ggctggggac cagtggacca gcagggtagg 60 ggtctctcct gctgcatccc accgggccca ggtcagcgcc ccgtgcaccg cggcgacccc 120 gcccactact gaatgtggca ggcggtggag gaagtggcct gacaacacat gcaggtgggg 180 ttcacagact tgggggggat gag 203 <210> 462 <211> 179 <212> DNA <213> Mus musculus <400> 462 aaggtaggac ccgcagagag gacagagggg cgggaccgag ccttggacgg gaggctagaa 60 cttagaggcc ccgcagcctg ggttagagat ccttgagcta gcagccaccc aacctgtcgg 120 gcacacacgg agccttgcct cccccaggtt cggcaccgac agtcgggaca agtcatggt 179 <210> 463 <211> 175 <212> DNA <213> Mus musculus <400> 463 ccgagtgcct gcagaccctg actacctacc ccgcactgag gtgaggtaac ctctgctctg 60 ggtgcctcaa ccaagaaggg ctttgtggag cttgagcctc acagtggggc acatggagag 120 cccactgaag gctaactggc agcccctcct ctgtccccac aggactttgg cctgg 175 <210> 464 <211> 142 <212> DNA <213> Mus musculus <400> 464 tgtaaagtca accaaggaac agacagtgaa gaaggcctgg aagggaagga ggagcagcct 60 gataggaaca taaagtgact tatgtatgaa caaagaaaac taacttgaaa aatggaggtt 120 accagggtaa ccggagtcat ct 142 <210> 465 <211> 143 <212> DNA <213> Mus musculus <400> 465 aatctgtacc caaccttgtc actggtccca gcagctgttt gaactcaccc gcggggatgg 60 cagcaaccct gcttctgaaa gaacagcaga agggcttacg tgcactgcgc cttgaagagc 120 cagcaaccct gcttctgaaa gaacagcaga agggcttacg tgcactgcgc cttgaagagc 120 gcctgaaagg aaggtcaaag gtc 143 gcctgaaagg aaggtcaaag gtc 143 <210> 466<210> 466 <211> 150<211> 150 <212> DNA<212> DNA <213> 小家鼠<213> Mus musculus <400> 466<400> 466 atgggaactg gagctgtccg aggccagcag gcgggatttc cgggaagcac tggcccattc 60 atgggaactg gagctgtccg aggccagcag gcgggatttc cgggaagcac tggcccattc 60 agatttacac cgagctctga cttccccacc tacccaccag cagctactga aggacccaat 120 agatttacac cgagctctga cttccccacc tacccaccag cagctactga aggacccaat 120 atagtttgca aagcctgtgg gctttcgttt 150 atagtttgca aagcctgtgg gctttcgttt 150 <210> 467<210> 467 <211> 138<211> 138 <212> DNA<212> DNA <213> 小家鼠 <213> Mus musculus <400> 467 <400> 467 gccccctgca ttttggcgga gggggaaagg agggaagacc aaagaaaaga aagcaaaaaa 60 gccccctgca ttttggcgga gggggaaagg agggaagacc aaagaaaaga aagcaaaaaa 60 ataaataaat agagcaagcc agagccgata tctacaaagt tttgcaccaa cacttaagca 120 ataaataaat agagcaagcc agagccgata tctacaaagt tttgcaccaa cacttaagca 120 gatccgtttg caaagtcc 138 gatccgtttg caaagtcc 138 <210> 468 <210> 468 <211> 203 <211> 203 <212> DNA <212> DNA <213> 小家鼠 <213> Mus musculus <400> 468 <400> 468 gcttccagga aaccattgga ctcggctccc aaagccgtgg acttgaaaga gaagcccagc 60 gcttccagga aaccattgga ctcggctccc aaagccgtgg acttgaaaga gaagcccagc 60 ttcctagcca agggatcaga aggccctggg aaaaactgtg tgccagtcat ccagcggact 120 tttgctccct cgggtgggga gcagagcggc agtgacacgg acacagacag tggctatgga 180 ggtgaattgg agaaggggga ctt 203 <210> 469 <211> 189 <212> DNA <213> Mus musculus <400> 469 ggggaagtgc ctcatgtaga gctcccggga gccacctcct gtccgtacgg cctggttcag 60 ctcccagtac aaggtgttgg atgagttggt gtacaccata atcgctactc cgtgctgggc 120 tttgaagcca ggaggtagag tgagcttgtg acgccggtgt gcccaggcct cttgtgctgc 180 ttcccagga 189 <210> 470 <211> 214 <212> DNA <213> Mus musculus <400> 470 agtgaccgct ctctctgctc tgcatccgcc ggctcggatg atcagtccct ctggaaatac 60 ccgggtttga ggaccccctt tggggctttt gtttttccga cttttggaac taaaccaaca 120 ctcctatcca atgggcccct tctgttgcct gcctcacacc ccctcctgct ccctttgtcc 180 cctcagcact gtccttacta actgaaggga gggg 214 <210> 471 <211> 171 <212> DNA <213> Mus musculus <400> 471 cttctgtctc catcaagaca ttatgaagct gtcctgtact gataccaaag ttaatgtcgt 60 ttatgggctc ttcatcatcc tatcagtcat gggtgtggac tccctcttca ttggcttttc 120 ctatatcctc atcctgaggg ctgtgttgga gctttcaact cgaggggcag c 171 <210> 472 <211> 145 <212> DNA <213> Mus musculus <400> 472 aattgtcttc tagctcacca ggctcctctg cagggctggg ccttcgacta gggctggaag 60 ttggagatgc agtaagccct ggtgatcgag gaactggacc tggggactca gagccaccta 120 ggctctgttg ccgaagaaac agagc 145 <210> 473 <211> 202 <212> DNA <213> Mus musculus <400> 473 cagtggccag gaagataaag ggcaggacag cagcttctgg gcctacgggc ctacgggcct 60 cttcagacca cagcagtggg caaaactggt gtcagacccc agtcagaaaa aacgagccca 120 agccagcaag taagtggcaa aggacatccc atgtccaatc tcctccaccc tggggctgcc 180 ccgcccagtg tccttcttga ta 202 <210> 474 <211> 153 <212> DNA <213> Mus musculus <400> 474 gacaaagcca aggcacccct tagagagctt ctccgaggtt cattacctac ccctagtttg 60 tctcttgccc caccttgcat ctcctccctc cacagcacaa ttaaggctaa gatcattctt 120 cttctctaga acgggcagag aaaatgggcc aga 153 <210> 475 <211> 154 <212> DNA <213> Mus musculus <400> 475 cgtggctgaa gagggtaagt gacgggctgc tttgtctggg tctctctgga gatgagtaag 60 gggagagaca ctttggggtg ttttggctgt gtgtgtgtgt gtgtgtgtgt gtaatagggg 120 aggtatttat ccagcgaacc ctattgtggc caag 154 <210> 476 <211> 172 <212> DNA <213> Mus musculus <400> 476 gttcctgatt ctcattaccc tggtaggaaa ccttggcatg atcttgctca tcaaggcaga 60 ttccaggctt cacacgccaa tgtactattt cctcagccac ctggctttca ttgatctctg 120 ttattcatct tccattgggc caaaaatgct gcaaaattta ttggtgaaga aa 172 <210> 477 <211> 158 <212> DNA <213> Mus musculus <400> 477 acactctgac acagccgctc tatgaaatga ttcagatgga atatgccagc gtgctttttc 60 cccccaaacc ctttcagaga gttatgatgt tgctacgtaa gttaatgaga ggaatggcag 120 agcaaacgct gctctcaaaa cctgtcaaca gtataact 158 <210> 478 <211> 177 <212> DNA <213> Mus musculus <400> 478 attgattttg aagttcaatg ttggcatctg ctgttattca aaaccaggac cttggctaca 60 gtaatccacc atgctttcgg cttcgccacc cgtgtgaggc aaatgaaggc aagctgttgt 120 cgagtgagaa atgcaaaata gccaatctgt ttgtctgttt aatgtaaccg ggaacat 177 <210> 479 <211> 211 <212> DNA <213> Mus musculus <400> 479 atggatcccc gcagactcca tacctggtgt ccgggggaga ggcagtgtga gcaaccgcag 60 agtcgggcta agggaccggc gggtggagac cccgtactct gtggcgtggg gcgagggaaa 120 actgattccc gcacaccagc ggatcgggcg gctcaccgat aaaggaaggc tggaagagcg 180 tctccgggca acggaaacgc tcattgccga t 211 <210> 480 <211> 159 <212> DNA <213> Mus musculus <400> 480 tgactttcac cttggtccag tacaactctc cagtcacgtt gaaggactca cactcgctct 60 tgttgttcac aatggtgtag ttcagaggca ggtccccttc ggtctggttg atgcacctac 120 cgaacttccc ggcgaagagg ttcacgccca tgatgctga 159 <210> 481 <211> 175 <212> DNA <213> Mus musculus <400> 481 cgaaagatca aaaattatcg atttcatggc gctgtgtgct ctggaaaaga aaagctactt 60 taacatttgc attgtttaaa gacatctttt agaagaaaag gctcgcaccc ccccacccca 120 aactctttgg gatgtgaaaa tggcttgttt tcatctccct catgattttc tataa 175 <210> 482 <211> 165 <212> DNA <213> Mus musculus <400> 482 atctctgacc tgctcttcct gctcacacta ccattctggg ctcactatgc tgcaaatgag 60 tgggtctttg ggaacataat gtgtaaagta ttcacagggc tctatcacat tggttatttt 120 ggtggaatct tcttcattat cctcctgaca attgataggt acttg 165 <210> 483 <211> 203 <212> DNA <213> Mus musculus <400> 483 cagggaaata attggcacat gtttaaaaaa aaattaaaaa cctcttggat gtgagtattt 60 tctaacagca tctggcggga gtgcctggaa ggaatttaat cagcgagagt tgtttaaatc 120 ggtctactcg ctcggcccca gcgaggctcc taatgaactc ggtatcatgt gccacccctg 180 cctgctgagg acattcaatt tgt 203 <210> 484 <211> 151 <212> DNA <213> Mus musculus <400> 484 ggaacagtaa agaaggtccg atcagtatgt acaaaagaaa gagcctgcta ccgtggagca 60 aggctgccac ttatgacacg gtgctccagg tctagaagaa ataaaacaac atccgtaaag 120 ctaaataatt ttaaaaactc tgtcacttat t 151 <210> 485 <211> 166 <212> DNA <213> Mus musculus <400> 485 atttcttctg ggctttccag agttatggtc acaaacctct tatcagaggt gatcaaagac 60 cgtggttcaa agcttgatgc accagaaatg tgagctaagg ctgcagccaa cacatccact 120 acccccttct cttctatcag tctttgagct gatggttgga aaaaat 166 <210> 486 <211> 147 <212> DNA <213> Mus musculus <400> 486 gtaatgttcc cactgtgttt aatgttcttc tgcttcttcc tgtctctcgg tggctccttg 60 agggctttga tgatcagggc tgaggcagaa ggcaccacct cgatctgggc ctgtctgttc 120 tggatggtca gtttcactgt aattctg 147 <210> 487 <211> 211 <212> DNA <213> Mus musculus <400> 487 taataaatgc caacggcggc aacaggcccc cttggccgcc cctggagtac caaccctacc 60 agagcatcta tgtcggaggc atgatggtgg aaggggaggg caagagccct ctcctgcgaa 120 gccagagcac ttcagagcag gagaaacgcc taacctggcc tcgcaggtcc tactcgcctc 180 ggagtttcga ggacagcgga ggtggctaca c 211 <210> 488 <211> 167 <212> DNA <213> Mus musculus <400> 488 cacaagggct tcagggacca aggccaactc ctctaagtcc cctcagctcc tgccttcccc 60 ctcccttgcc agggacattt ggctcttcta agcaggctct gttcaccagg aggattcccc 120 tcttgccaag tttggtgcgc agagctacag atgggaccaa agggagt 167 <210> 489 <211> 182 <212> DNA <213> Mus musculus <400> 489 gcctgtatag gcaggtacca gtaaatgtta aaagaatgaa gttactcctt gctcatcctt 60 cacctaccaa gctagagaca ggaaaaggcc cgtgccatta agagtctgtt cttgaaggca 120 gagaacagaa gagtgacctt cttctacccc ctaagacctg ggtcagtctc aaacagtcca 180 gt 182 <210> 490 <211> 170 <212> DNA <213> Mus musculus <400> 490 agcagcacac tcaaggacag gctcaaatgc tttcctctgc ctgggagttc aagcattcat 60 gaggaaaaaa aaaaatcaag agggatttta aaataaagcc catgctctct gcaggctgtc 120 tgctctgagc cagcgcagcc gtggggtgat tatggaggaa ggaatggttt 170 <210> 491 <211> 181 <212> DNA <213> Mus musculus <400> 491 tgtaaaaaag aaacacggtt tgttaggcag aaaccatcag ggtaggaaac aggcagacag 60 gacagggtaa agtaccaact gggcttttgt ccctcccccg atctcagtga ggacggagga 120 aggacatttt gtgctacagc agctgttttt gtactggtca gatggggtgt gagatttttg 180 c 181 <210> 492 <211> 214 <212> DNA <213> Mus musculus <400> 492 acagtgcgtc ctaattacac actccgtcgt gacaggcggt gtcaaagatt aaaggaatca 60 aacccagggg ctctccagga caccccccac ctcaagaacc agagtgcgat tatggtacca 120 aggtagaagt taggaagata attttccctg ggtccaagct gcatgtcagc atcttgtctc 180 agctaccttg tctgggctcc tcgggttcat ttgc 214 <210> 493 <211> 163 <212> DNA <213> Mus musculus <400> 493 ctccgcaagg tgaggccggg agcctgggag tcaggggtgc agggacccaa gctaggatgc 60 gccgtggcca ctcacaggca tccccatccc ttggcaggtg ggctcctttg atccctacag 120 cgatgatccg cggctaggca tccagaagat tttcctctgc aaa 163 <210> 494 <211> 195 <212> DNA <213> Mus musculus <400> 494 cacttgatga gcagaagtcc agtgtggtgc tgatctgggt cagtcattca caagagacca 60 ctgcactttg atgtggattt tgtagggggg aggggtaaag aaccagtttt gtcaacaggt 120 actgatgatc acaggcagtt gctattatta ggactcaaat tttgctttct ttgacactgg 180 tagtgtgtct tcctt 195 <210> 495 <211> 187 <212> DNA <213> Mus musculus <400> 495 gagtcaaaaa aaataactat atatcatttt aaattgctct ggctggtacc tctgcatttt 60 aaggatatca aggtggggga aatgtgctta atgacaggac tacacgtgga taaagggctg 120 acagggtgat tgcgatacca ggtgctccca cacacccgtt agcttcttcc tttctgggcc 180 tccgaag 187 <210> 496 <211> 200 <212> DNA <213> Mus musculus <400> 496 ctcagtgttt agaataaagc cagattgttt tcaggcccag ttccgcggca gagtttgtat 60 gcacggcaat ctcaaacatt tcctcgttcc ctctaaaggc aaagccaatc tcatttgaaa 120 tggaggttag agtaaaaaaa aatcacttct gtgttttacc accttctgcg ctaagtatta 180 tctcaacaac cttttgctct 200 <210> 497 <211> 181 <212> DNA <213> Mus musculus <400> 497 gcggtatagg gaaggggagt ttcaggacaa aaggccagca cacaagagct ttacccaggt 60 acttagagac agagtggagg ggcgctctga ctgctactta cacaagtcct cggatgacag 120 atcagattcc tgaggtctgg aaagtgttac ataccattat tctaaacaag gctatgagat 180 a 181 <210> 498 <211> 142 <212> DNA <213> Mus musculus <400> 498 aagaaaggtc tcattgatta tgacaccttc aaggagctat gtgaacaaga gtgcgaatgg 60 gaagaaataa ccatcacagg atcagacggc tccaccaggg tggtcttagt ggacaggaag 120 accggcagtc agtatgacat tc 142 <210> 499 <211> 161 <212> DNA <213> Mus musculus <400> 499 gcacatcctt tgtatcatga aataaaacag ggccctcaag aaaagtaact ccatatgcag 60 ccctgccctc ttagggcgcc gaggaaggct ggagccttgg cactctgtgt ggtggtggct 120 ccctttctct ttctttcctt tcctgtgaca agcagccatt g 161 <210> 500 <211> 214 <212> DNA <213> Mus musculus <400> 500 cgctgaatgc cttctcaggc agcagggagt tgctcacgga tgtagtgtcc tgaagcagca 60 gctcctgctc tggggcgcta ttgcgctgtc catagaggtc ggtgcccacc gccaggagcc 120 gcccagcgga acccaccacg gtcacgtcct gcttgaactc tccaggcaca ttgaagttca 180 gggtaacggt gcagcacact ccaccctcca gcac 214 <210> 501 <211> 161 <212> DNA <213> Mus musculus <400> 501 gagtgcaggc cgccaccacc catcaggtcg tcgcagctcc agttgtattt cttgcccagc 60 agactaccgc tgtgcacctg cacctcgcac accagcagct cgcccacgta gccctcctca 120 atcagctgct tcatgcgtac gaaggctggg aggaagcgca g 161 <210> 502 <211> 139 <212> DNA <213> Mus musculus <400> 502 tttcccaccc cgaggaggac gaagcagagg tcagtactag tggctttgta catgaatgga 60 ccttcccctc catccccttt cacatgtggt ccagcaacag taacagacag atgcgacaca 120 aaaagagaca cacctgatt 139 <210> 503 <211> 191 <212> DNA <213> Mus musculus <400> 503 ggttgggggg gaggcactaa acaaaaggaa ccacaggcct gtttactaga gagaaggctt 60 aattggcttc agagaaagtg caggaagtgt gtgggtttgc tgctctcgtt tgtcgggggc 120 cccagtgaaa ggctggaagg gacagagatt ctggctcccc ccagccccga ctgtctggcc 180 cctccctctc t 191 <210> 504 <211> 148 <212> DNA <213> Mus musculus <400> 504 aatagaacag taacggcaca cagagagatg gccaatgaga gcagctttca gtgatgtcat 60 acttatacct gcttcttatt atttgctgaa tggtaacaat gtgtgccttt aatcttacat 120 ttcattggtt aaaagccctg ccattcta 148 <210> 505 <211> 193 <212> DNA <213> Mus musculus <400> 505 gaatcgtgct gggttgtgtg atatgatttg gagaagagaa ctgactgccc taaaatgaaa 60 aagacgaagt aattttccat aggcttttga atcctaaggt ttaccctcct gttcccccta 120 tcgtccatct aaagattaaa gagtgaaaca atcagcggat tttaaagtga aggggaaggg 180 agggtggtct gca 193 <210> 506 <211> 178 <212> DNA <213> Mus musculus <400> 506 taatagtgtt agtgtaaacc taccctaaag ggtcagactt gctaatacac atgtaatcct 60 ttccatggaa gatcatctcc cttgagaaaa ctatccaatc atgaaaggta atgaagactt 120 gcagcaaagg tctgacactg aatatggaat aagtggagga tgaggtagct aggttttg 178 <210> 507 <211> 126 <212> DNA <213> Mus musculus <400> 507 cttaaaaaca tggaggacga tgtcctgcag gaggttaccc cagtcacaag gctgcgagcg 60 ctcctgtgtc gtcctcggtc tcttgggctt ctcggcagtg ccttcctcag cagagtcctg 120 gtcact 126 <210> 508 <211> 147 <212> DNA <213> Mus musculus <400> 508 aacactcctc ttgaactcct gccagaatcc cggagctgaa gctcccctgc gtggcagagc 60 tgacctatgc tctcaaagcc taattaattt gcagaggaat gtcaaaatga caggtccacc 120 acctgcttca cttgacactt aaaagga 147 <210> 509 <211> 214 <212> DNA <213> Mus musculus <400> 509 cgagaggacc tactgtcgcc ggtgcaggac gctgatcgct tttacagggg cattttagag 60 ccagacaaac actgctccac tacccctgcg ggcagcagcc tcccagaata ccctaaattc 120 ccatgcagcc cggctgctta cactttctcc ccaaactatg acctgcgacg cccccatcag 180 tatttgcacc cgggtgcagg ggagagcagg ctgc 214 <210> 510 <211> 153 <212> DNA <213> Mus musculus <400> 510 agggatttca taacaaggaa ccagtgtgca cgccaaaggc tgttgctggt tgactagtgg 60 ttttggcggc tggtcctggg cagttgctgc catctgttcc ataaaactgt tttttagaaa 120 gatatataaa acaattaaca agtcagaatt cta 153 <210> 511 <211> 145 <212> DNA <213> Mus musculus <400> 511 aaagaatatc tcagtagcca atatttttct ctgctggtat caaatgaaat tcatttggta 60 tcagctggag tttttatagt gctaatggaa gttattttca gttatcacgt cagtctgtaa 120 gtatacaaag gcggcaattt cgctg 145 <210> 512 <211> 187 <212> DNA <213> Mus musculus <400> 512 tctcatcagg accacagtag ggcagcttga tggtgagtga ggtgagagat atggaatgga 60 tggtcccccc tgtccatagg gctgctgcca gcatcataca caccttccag ttcattattg 120 tcatatactg caaaggttta caaatagcca catagcgatc ataggccatg acagtaagaa 180 ggaagat 187 <210> 513 <211> 189 <212> DNA <213> Mus musculus <400> 513 gagacatctg gaagagagag ccatgaggca ttaatgtgct tggtggtagg aagaattggg 60 agatggtaca aaaaaaagag atgggattgt ggcacccaat gtcactggtg actccttgaa 120 aatggaaaat attagtgaaa attctgttgg tgccaccctt tgatcagcat ttatctcatc 180 ccaggttct 189 <210> 514 <211> 137 <212> DNA <213> Mus musculus <400> 514 agcttatgcc ccccacccct gcaacatttg gctccttggg atctctgagt caccctctga 60 ccttgaccgt ctgtaggaag ggcctacact cgttgagcca acctcatcca agagggctta 120 ataagcactt ggcggct 137 <210> 515 <211> 162 <212> DNA <213> Mus musculus <400> 515 attggtctag ccgtcacatg gtgaggaccg aatgcgcgga taattatgga gctgatattt 60 cccccctccc cttctttttc ctcccgcccc tccaaccgct ccccccccct tcccggatgg 120 gggaaaaaag atgtcagctc ctccgctgta gtattgctcc tt 162 <210> 516 <211> 207 <212> DNA <213> Mus musculus <400> 516 ccagtggatt tgaattcggg gggaatttcc caaactgaca atcctctagg gccttagaga 60 gcttcttcct attcttccac ccttgggatt ttctatcccc tgttcttcta aggagaggga 120 aggcaagtgt ggggaaggag agcctcagcc tgctcacacc ctgtggcttg caagtccccc 180 tcagtgctgc ctttgtctcc acaggtg 207 <210> 517 <211> 199 <212> DNA <213> Mus musculus <400> 517 atttttatca atctcaccaa ggatgaattt gcgtgagtac aggccagcat gtgccatccc 60 cgaaactctt atccaagcct tccccccccc ccttatcttt tagtcctacc ccttgctgaa 120 aggactggtc tcttctctgt ttgtccactt agagagctgc gggccctggt tatcgagatg 180 gtgttggcca cagacatgt 199 <210> 518 <211> 203 <212> DNA <213> Mus musculus <400> 518 aacatcactt tagtaaattg tgattttttt aaaaaaagcc atgatttatt gatgtgagtg 60 gcttgttttc atgtggcgcc agaaatgaac ctgtttaaaa gctataacca atggtactga 120 tctatccatt aaatactgtc cttaaactgt agtttaatag tattgtcaac taggaaagct 180 aaaatggttt ttgttctgtt gaa 203 <210> 519 <211> 150 <212> DNA <213> Mus musculus <400> 519 cctccctact catcctttgg gcaaacagtc cagaaagccg aggttgccaa gacgcaaaag 60 gaacagtggg gggtggggca cgttccttgc ttctcttgcc ccctggtttc cttttatttt 120 caggggtgga ggggagggca cttgtctcga 150 <210> 520 <211> 191 <212> DNA <213> Mus musculus <400> 520 tcatatcttt cagtctccac ttgtgtgggg gaggtggggg cgggacaccc tccttttctc 60 ttgaccccgg ggcttctgct cttcctcatt ggaaggaggg tggtggcctg gtgagaggcc 120 cctgcctcgg agcgcctctc ttcagagaac tacctgccgc ccattgtggg ctggccagga 180 agcccggctt t 191 <210> 521 <211> 124 <212> DNA <213> Mus musculus <400> 521 tctaattatt gggcttaaat tgcattagtg tgctggcaat ttgtctaccc ctggaaaagt 60 aattgacatt tgggttactg cttcatatgt gggcgacttg ctagccagtt ccaaagagtc 120 ctct 124 <210> 522 <211> 155 <212> DNA <213> Mus musculus <400> 522 acatggtcct aaggatctat cgactctggg cacacgagaa gattgatcaa tccggcagac 60 tcacattaat tgtgaaatag aaaggaacgg tgcgatcaat ggtgaggatg aaagtccgcc 120 cgatgttgcc acatccagct aatccgataa tgaag 155 <210> 523 <211> 157 <212> DNA <213> Mus musculus <400> 523 ctacagcaaa aaattcacaa agcctccccc ccccccaaaa aaaaaagaga gtagaggtgg 60 ggggagggga gagagacttc ttccccagtt ccctcactga ggaagttgtt ggttggctga 120 atgctgaagc agttccaccg cataattttt tttctgt 157 <210> 524 <211> 199 <212> DNA <213> Mus musculus <400> 524 cagtggtctg atggaagcag ctcccagttc cggtaagcta tgactggatt ccgaagtgtt 60 aatttgaacc ctgctggagt cagtgtggca caagaaaagc tatgatacat attgctaagt 120 gtccccatgg gtctctattt gtagaaactg gtacactgat gaaccttctt gtgggagtga 180 aaaatgtgta gtcatgtac 199 <210> 525 <211> 185 <212> DNA <213> Mus musculus <400> 525 attgggtagc gtaatggaga ctgtggcaat gtgccaaccg aggagtcaat gggaaaggaa 60 taagaggcat aatgagttat gtggagaaag gagcaggtgg gccaagaaaa ttggacacca 120 cgaggactct gtaaaatcaa gtgattgaat tatagctcta aggagatgta taatgggaat 180 cactg 185 <210> 526 <211> 136 <212> DNA <213> Mus musculus <400> 526 ttcacagaag tatgcctcct tgtctaatct gagaagccat tggcgggaga ttgatgggca 60 gttacagaga agtgtttcag gaggcggctg tatgctcaga ggtaccagaa tagagctatc 120 tgtcttcatt gaaccc 136 <210> 527 <211> 150 <212> DNA <213> Mus musculus <400> 527 agccaccagc ttcctgtgcg gggccaatgg gacaggcttc agttatctaa gacaattaat 60 tcatttggtg ccaactcctg tggccgttaa ttgttcagcg tttccatgtt caggaactcc 120 tccccgcgga ctggctgcct gtgacgtcac 150 <210> 528 <211> 194 <212> DNA <213> Mus musculus <400> 528 gaatgttggc atggtgtagg aaacaaaagt caacttaaca accaaaaagt tagttcctgc 60 aggaaagatg gctatgggtc ctgggacaca cacacacaca cacacacaca cacacacaag 120 ggttgatgag gttgattgca ctaagtgact gctaaaggcc ctggtgtgtc ttggacttgc 180 agcctttgtc tgca 194 <210> 529 <211> 188 <212> DNA <213> Mus musculus <400> 529 cacacagatt ggtatcttca aaaaggccaa cctggtaggc ctcacttgcc tcctgcaaag 60 caccaatagc tgcactctgg aagcgcagat ctgttttgaa gtcctgagca atttctcgca 120 ccagacgctg aaaggggagc ttgcggatca gaagttcagt ggacttctga tagcgtctga 180 tttcacgg 188 <210> 530 <211> 172 <212> DNA <213> Mus musculus <400> 530 caggtggctc cattcctgca cggcttatgg tgagtacagt agttcaggtc tgcccgggtg 60 gagacaggaa aggggacagg aagcccaagg tcaaatacag gaaggatcta tgtttccagt 120 gggcattggg ctgctttgag gagacctggc aatcttagag gagggcctta cc 172 <210> 531 <211> 203 <212> DNA <213> Mus musculus <400> 531 tactgtggag ctgtggcaaa gagacaggag agaagggggg tggagccgca tcagggtcgg 60 ggcactcctg ctttgccttt caaagaaacc caggagctat tacttagtcc tctgacgcag 120 gatagtcctg ggttggttgc cacagcagag agtggcagcc tttctgccag cacttctgtt 180 tcagattcat cccagaaaaa aga 203 <210> 532 <211> 208 <212> DNA <213> Mus musculus <400> 532 tttgagcaac agacagcaga gctactgcta ctgtggaggc cctggagagt gagtggagag 60 ggtgttgtca agctatggga tgggggttgt tgtggtggca gagcccggga aaatgggtga 120 acagggggcg agggggccct gtggtttcaa gaaggctgtc tgagggccac aagcgctgtc 180 tcccctccag gtggaacctg aaaatgct 208 <210> 533 <211> 187 <212> DNA <213> Mus musculus <400> 533 cagctgaccc atctggagct ggacgaagag gttctgcaga atgttctgga attgcctacc 60 tggctggcca tcactagggt ctactgcaat cgggcctcca tccaggtgag agtggggtct 120 gagcactgtg cgtcccgagc cagcaggctt gttcacttaa ggagcggctg tcacaggcct 180 gcatctg 187 <210> 534 <211> 133 <212> DNA <213> Mus musculus <400> 534 aaatggatgt gctgctgccc cagcggagct cagacaggat gaaatggaag caggatgagg 60 ctgcaggcgg ccttcctggt gccgatgcca gtaccggtgc ctgcctcctg agctcagtca 120 tctgcaggac ccg 133 <210> 535 <211> 200 <212> DNA <213> Mus musculus <400> 535 agcaacctac agagccggcc ggagaccctc tgccttcata gttataggtg aggacatagt 60 cttgggatgg gatgtggtct tcattctgat tacacacatg caatttctgt aaagtccaaa 120 aaagaggatt gtattatttt tttaaaacaa cttcaacata tgaacagaaa atttatttta 180 tttacctttt atgtttaatt 200 <210> 536 <211> 157 <212> DNA <213> Mus musculus <400> 536 aatgaaacac cttacatatc acttcatctg gagagcctga attgacagca gcgggtgtaa 60 tttatacatc ctttcccccc atctgttagc attcagtctt caggctgtcc tgtgtgtgtg 120 tgtgtgtgtg tgtgtgtgtg tgtttcttca attctct 157 <210> 537 <211> 145 <212> DNA <213> Mus musculus <400> 537 atagtccctg attcttcttt caatgagtct gcagaggaga gagagactgc ctgaagattg 60 tgcacctcag ccttcccctt cctacggagc acgactcttc cctgcagcta gctagctctc 120 ctttcttttc aggctggcct gtcct 145 <210> 538 <211> 136 <212> DNA <213> Mus musculus <400> 538 aggatcttgt ttcctcagct cattgaaaat agaaagggct ttgtcgatat ctgcagaaag 60 aaagcagagt ctaaaaccca tctaactgca cctctgcctc tgtcagcatc cagggtcctt 120 agtcactcac ctctga 136 <210> 539 <211> 217 <212> DNA <213> Mus musculus <400> 539 ggccgcggcc catggagctg taggagccgc ggtaggtagc ggagggcagg tggtgctggg 60 gcctcggggc gggcaccgcg accgtccctc cctctctccc atcccccagt ccagccgctg 120 gtgcggcgga gcctcctagg ccgtctcggc gggagaaccc gggacccggt gggggagggg 180 gtggcggagt gcatgtccca gaccctcccc atcccct 217 <210> 540 <211> 158 <212> DNA <213> Mus musculus <400> 540 catactctat tgtattattt ggagttaaat cctcactttg ggggaggggg gagcaaagcc 60 aagcaaacca atgatgatcc tctattttgt gatgactctg ctgtgacatt aggtttgaag 120 catttttttt ttcaagcagc agtcctaggt attaactg 158 <210> 541 <211> 161 <212> DNA <213> Mus musculus <400> 541 tcaataggga aataacaaga tgtcacttca aataactctt ccacgaaagg tcctgcggca 60 acagagaaag gataaagttg acttgggctc attacctctg agcagcttca accagctaat 120 tcagtgctat gaaaacctac ccagactgta gtccttggag a 161 <210> 542 <211> 202 <212> DNA <213> Mus musculus <400> 542 ctgtcccctt ttgacaccat tcctgattca gagctgctcg tgtcccctcg ggagagctcc 60 tctgtgagta tggcatcagg gagggataca gggctagtcc gaaggttcca accacgtccg 120 ggagcctcta catatagctg tgcacaaact gatcggggcc tttcttcctc tcagctgcac 180 aagctgctca atctctctcg ga 202 <210> 543 <211> 199 <212> DNA <213> Mus musculus <400> 543 ccttcaggta agtgggaggg gagaacaacc aggctaatgg ccaagagctc gtaggccggc 60 tctacttgct gggtcagccg gcagcagtgt gaagctcgta ggccggctct acttgctggg 120 tcagccggca gcagcgtgaa gctgtgcttt gattccactg aggctttaga gactcactgt 180 ttccaaacaa ggagctcgg 199 <210> 544 <211> 185 <212> DNA <213> Mus musculus <400> 544 gcccctccca tggaggtttg ccaggtgcct ccagtgagaa gggccggaag acctatccta 60 ctgtcaaggt gagctcagat gacaccggag ggtagggatg gtgtatgggg caactactga 120 ctatcctttg ccattctcag atctgtaact atgagggacc ggccaagatt gaggtggacc 180 tggtg 185

Claims

1. A method for identifying a human or mouse sample, the method comprising: obtaining nucleic acid from the human or mouse sample; Using next generation sequencing (NGS) to detect the genotype of the sample at a single nucleotide polymorphism (SNP) locus, wherein the SNP locus comprises (1) a human SNP locus of the group SEQ ID NO: 1-237 as shown in Table 1, or (2) a mouse SNP locus of the group SEQ ID NO: 238-436 as shown in Table 2; comparing the genotype of the human or mouse sample to a reference genotype; and The human or mouse sample is identified.

2. The method of claim 1, wherein the human or mouse sample is a cell, a tissue, an organoid, or a combination thereof.

3. The method of claim 2, wherein the human or mouse sample is a cell line or a tumor tissue.

4. The method of claim 1, wherein the human or mouse sample contains a contaminant, and the method comprises determining the percentage of the contaminant in the human or mouse sample.

5. The method of claim 1, wherein the human sample comprises a contaminant, the method comprising determining the nature of the contaminant. The method of claim 1 , wherein the nucleic acid is barcoded.

7. The method according to claim 1, further comprising identifying the sex of the subject from which the sample was obtained by detecting a sex chromosome SNP locus selected from the group shown in Table 3.

8. The method of claim 1, further comprising identifying the race of the subject from which the human sample was obtained.

9. The method of claim 1, further comprising detecting the presence of viruses or mycoplasmas in the human or mouse sample.

10. The method of claim 1, wherein the mouse sample is a mouse tumor model selected from the group consisting of 4T1, A20, B16-BL6, B16-F0, B16-F1, B16-F10, C1498, Colon26, CT26WT, E.G7-Ova, EL4, EMT6, H22, Hepa1-6, J558, J774A1, JC, KLN205, L1210, L5178-R, LLC, MBT2, MC38, MPC-11, Neuro-2a, P388D1, P815, Pan02, Renca, RM1, S91, and WEHI164.

11. A method for identifying a sample comprising a human component and a mouse component, the method comprising obtaining nucleic acid from the sample; Using next generation sequencing (NGS) to detect the genotype of the sample at the mouse genomic loci of the group of SEQ ID NOs: 437-544 as shown in Table 6, each of the mouse genomic loci having a corresponding homologous human genomic locus, wherein each of the mouse genomic loci has a consistent flanking sequence with the corresponding homologous human genomic locus; and The ratio of the mouse components in the sample is determined based on the genotype.

12. A kit for identifying human or mouse samples, the kit comprising: primers for detecting loci in the sample using next generation sequencing (NGS), the loci including (1) human SNP loci of the SEQ ID NO: 1-237 group as shown in Table 1, or (2) mouse SNP loci of the SEQ ID NO: 238-436 group as shown in Table 2, or (3) mouse genomic loci of the SEQ ID NO: 437-544 group as shown in Table 6; and reagents for amplifying DNA fragments containing the loci using the primers.

13. The kit according to claim 12, further comprising primers for detecting sex chromosome SNP loci selected from the group shown in Table 3.

14. The kit according to claim 13, further comprising primers for detecting viral infection or mycoplasma contamination in the sample.

15. A microarray for identifying human or mouse samples, the microarray comprising: probes for detecting loci in the sample using next generation sequencing (NGS), the loci comprising (1) human SNP loci of the group SEQ ID NO: 1-237 as shown in Table 1, or (2) mouse SNP loci of the group SEQ ID NO: 238-436 as shown in Table 2, or (3) mouse genomic loci of the group SEQ ID NO: 437-544 as shown in Table 6.

16. A non-transitory computer readable medium having instructions stored thereon, wherein the instructions, when executed by a processor, cause the processor to: Using next generation sequencing (NGS) to detect the genotype of a human or mouse sample at a locus, the locus comprising (1) a human SNP locus of the group SEQ ID NO: 1-237 as shown in Table 1, or (2) a mouse SNP locus of the group SEQ ID NO: 238-436 as shown in Table 2, or (3) a mouse genomic locus of the group SEQ ID NO: 437-544 as shown in Table 6; comparing the genotype of the human or mouse sample to a reference genotype; and The human or mouse sample is identified.

17. A method for identifying a sample comprising a major component and a minor component, the method comprising: Using next generation sequencing (NGS) to detect the genotype of a human or mouse sample at a SNP locus, wherein the SNP locus includes (1) a human SNP locus of the group SEQ ID NO: 1-237 as shown in Table 1, or (2) a mouse SNP locus of the group SEQ ID NO: 238-436 as shown in Table 2; The SNP heterogeneity ratio of each of the SNP loci is determined according to the formula shown in Table 11; determining a sample heterogeneity ratio based on the SNP heterogeneity ratio of the SNP loci using a Gaussian mixture model that simulates the genotypes; and The major components of the human or mouse sample were determined as follows: comparing the genotype of the human or mouse sample to a set of reference genotypes, each of which is detected in a reference sample, identifying a reference sample having a reference genotype with the highest concordance with the genotype of the human or mouse sample, The major component is determined to be the reference sample if the following conditions are met: The reference genotype is more than 90% consistent with the genotype of the human or mouse sample and the human or mouse sample heterogeneity ratio is less than 10%, or The reference genotype is more than 80% consistent with the genotype of the human or mouse sample and the human or mouse sample heterogeneity ratio is greater than 10%.

18. The method of claim 17, further comprising determining the minor component of the human or mouse sample.

19. The method of claim 18, further comprising determining the percentages of the major component and the minor component in the human or mouse sample.

Citation Information

Patent Citations

  • Microarray synthesis instrument and method

    US20070037274A1

  • Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof

    US5143854A

  • Very large scale immobilized polymer synthesis using mechanically directed flow paths

    US5384261A

  • Method of synthesizing diverse collections of tagged compounds

    US5708153A

  • Tagged synthetic oligomer libraries

    US5770358A